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1CHAPTER 1. INTRODUCTION
Diabetes mellitus is a condition where the body’s ability to control its blood glucose
concentration (BGC) has been impaired or destroyed. Unfortunately it is a growing prob-
lem throughout the world, as Zhang et al. [114] report that the global health expenditure
for diabetes is projected to be at least 375 billion US dollars in 2010 and at least 500
billion US dollars in 2030. There are many reasons for this, including a rising population,
a longer lifespan, as well as poor eating and exercise habits. [115] This has caused diabetes
to become the seventh leading cause of death in the United States as of 2007. [14]
There are two main types of diabetes mellitus. Both of them affect the body’s pro-
duction of insulin, a hormone produced by the β cells of the pancreas that triggers cells
to uptake glucose for energy or fat storage. Type 1 diabetes mellitus is a condition where
the β cells are destroyed by the body. What triggers the body to destroy the β cells is
still being investigated, though it is believed to be an autoimmune response. [21] Type 2
diabetes mellitus is characterized by poor control of the body’s BGC. This can be caused
by cells developing insulin resistance and/or the β cells’ inability to produce a sufficient
amount of insulin for glucose uptake. Those with type 2 diabetes are at higher risk for sev-
eral other health problems, such as obesity, high blood pressure, nephropathy, neuropathy
and blindness. [21] While the onset of type 1 diabetes generally occurs before the age of
30 and type 2 diabetes after the age of 30, an increasing number of people, particularly of
Pacific Island or south Asian descent are experiencing the onset of type 2 diabetes in their
220s. [114]
To decrease the risk for other health problems, diabetics need to tightly control their
BGC. [105] Typically this means to keep one’s BGC between 70 mg/dL and 180 mg/dL.
One is said to be hyperglycemic when their BGC is above 180 mg/dL and hypoglycemic
when under 70 mg/dL. When hyperglycemic, organs that do not require insulin to uptake
glucose, such as the kidneys and eyes, are subjected to an excess of glucose, which causes
damage. When hypoglycemic, the brain begins to shut down organs because the body does
not have enough glucose to keep them running. Thus if one is hypoglycemic for too long,
one can experience diabetic shock, a coma, or even death.
From this one can see that the development of an accurate glucose model could have a
significant impact on glucose control, and thus improve the well-being of a type 2 diabetic.
Thus the main objective of this work is to enhance glucose modeling via the advancement
of statistical methods and theory to achieve the ultimate goal of the development of a
noninvasive continuous glucose monitoring system (CGMS). To this end, since one’s BGC
is dynamic and the relationship it has with other factors is complex, the use of a nonlinear
dynamic model is a necessity. Thus the following conditions and model assumptions define
the scope of the proposed research:
1. Non-insulin dependent type 2 diabetes mellitus
2. Free-living conditions
3. 2nd order nonlinear dynamic behavior
4. Serially correlated noise
5. Multiple inputs
6. Time and space variant parameters
3The development of an accurate glucose model is very important to the development of
a noninvasive CGMS. This noninvasive CGMS must be able to provide accurate predictions
of one’s BGC under free-living conditions, i.e. conditions that are typical for a human being
during the course of their day. This will not be an easy task, as a type 2 diabetic’s ability
to regulate their BGC will degrade over time. Thus regardless of the model chosen, the
parameters will be time variant. The sensors needed to measure multiple inputs must also
be highly accurate. This glucose model must also not depend on insulin, as this device is
intended for those who do not take insulin.
In the next chapter several approaches that have been proposed for modeling BGC will
be discussed. After this, a discussion on the devices that have been used to monitor BGC
noninvasively will be given. Then an overview of several current models for predicting
BGC and current methods for calculating (1− α)100% prediction intervals for forecasting
purposes will be given. In subsequent chapters, papers to be submitted for publication that
address the issues of building a model that accurately predicts BGC and the construction
of predictions intervals for BGC are given.
My contributions to each chapter are as follows. For Chapter 3, I created the algorithm
and wrote the paper. For Chapter 4, I helped in collecting the data from the subjects and
contributed the result given in the appendix for that chapter. For Chapter 5, I generated
the results, performed the derivations and wrote the paper.
4CHAPTER 2. BACKGROUND AND LIMITATIONS OF CURRENT
METHODS IN GLUCOSE MODELING
In the literature there are several methods that have been suggested for use in glucose
modeling. These methods vary widely in their structure and have had varied success.
While each of these has its strengths, each also has its issues. In this chapter several
models that have been used for glucose modeling will be discussed. After briefly discussing
their history, a short history on the use of noninvasive devices for measuring BGC will be
given. After this several models that are currently being used will be introduced. Finally
current methods for calculating (1 − α)100% prediction intervals for future values of a
response variable will be given.
2.1 The History and Role of Glucose Modeling in Improving Glucose
Control
Researchers have been modeling one’s BGC for over 50 years in hopes of finding an
accurate model for one’s BGC. This has occurred despite the fact that the technology
needed to continuously monitor one’s BGC under free-living conditions has only become
commercially available in the last ten years. In this section several approaches that have
been used are introduced, and the section concludes with a discussion of the issues found
in each of the studies mentioned in this work.
52.1.1 Compartment Models
Compartment models were the first models used in the modeling of blood glucose
and insulin. Compartment models are models described by a set of linear differential
equations. A major advantage of compartment models is that one can have multiple
inputs and multiple outputs of interest. For example, a simplified compartment model for
tracking changes in blood glucose and insulin concentrations when glucose is administered
intravenously is suggested by Bolie [10]:
dx
dt
= p− αx+ βy (2.1)
dy
dt
= q − γx− δy. (2.2)
Here x represents the measured extracellular insulin concentration and y the measured
extracellular glucose concentration, both centered with respect to the mean insulin and
glucose concentrations, respectively. Also p denotes the rate of insulin injection divided by
the total extracellular fluid volume and q the rate of glucose injection divided by the total
extracellular fluid volume. Finally the coefficients of x and y in these differential equations
are parameters to be estimated. Segre et al. [92] modified these equations to allow for the
use of insulin infusion and Ackerman et al. [1] modified these equations for an oral glucose
tolerance test. More recent work in modeling BGC with compartment models include Topp
et al. [103], Ribbing et al. [84], and Karimipour and Shandiz [52].
Cobelli et al. [21] note two major drawbacks to Bolie’s model. One is the simplistic
assumption of a linear relationship between insulin secretion and glucose. The other is
that this model does not take into account the complex interaction between production
of glucose by the liver and uptake of glucose and insulin. For modeling BGC in type 2
diabetics, another drawback is that the true rate of glucose injection from the digestive
system and the amount of insulin in the blood cannot be measured noninvasively. Thus
6determining the optimal rate of insulin infusion at a given time would be very difficult.
2.1.2 Empirical Modeling
Empirical models are models that do not take into account any information about the
true model. In this situation, one chooses a model and determines parameter estimates from
collected data. An advantage to this is that parameterization may be kept to a minimum,
but an obvious problem is that if the model structure chosen is grossly inaccurate, then
determining an accurate model from the chosen model structure may be impossible.
Several empirical models have been used in the literature. The simplest such model
is the autoregressive model. Sparacino et al. [96] fit first-order autoregressive model with
time-varying parameters to predict blood glucose concentrations 30 minutes into the future
with a fairly high degree of accuracy. Reifman et al. [83] achieve similar results with a first-
order autoregressive model fit using the regularized least squares method, which introduces
a small amount of bias in return for a sizeable reduction in the variance of the parameters.
The next empirical model to consider is the autoregressive moving average (ARMA)
model. Eren-Oruklu et al. [25] use an ARMA model to predict future BGC. St˚ahl and
Johansson [99] consider several models, including compartment models, AR models and
ARMA models for predicting current and future BGC.
Autoregressive exogenous input (ARX) models have also been used. Pedersen and
Hansen [79] consider ARX models in the prediction of a type 1 diabetic’s BGC. Finan et
al. [28] consider them for predicting BGC in simulated data. Finan et al. [27] use them
while investigating the effect of smoothing input data.
Another empirical model used for modeling BGC is the autoregressive moving average
model with exogenous variables (ARMAX model). St˚ahl and Johansson [99] consider them
in their comparison of models. Eren-Oruklu et al. [25] use an ARMAX model in order to
7predict the onset of hypoglycemia. Finan et al. [27] consider these models as well while
investigating the effect of smoothing the input data on the ability of an ARMAX model to
predict BGC.
The last empirical model to be discussed is the artificial neural network. Mougiakakou
and Nikita [71] use them to determine the amount of insulin to administer for a type 1
diabetic in order to control their BGC. Paddada et al. [77] and Tresp et al. [104] use neural
networks to predict BGC in type 1 diabetics.
2.1.3 Semi-empirical Modeling
Semi-empirical models are models that use first-principle, i.e. biological, chemical, etc.,
laws in conjunction with an empirical model. This allows for models where some informa-
tion about the true model is known, but there is still some uncertainty in the true model
structure. The only semi-empirical model to be considered in this work is the Wiener
network. While it has not been used extensively for modeling in the diabetes field, it has
been used extensively in the chemical engineering field to model gas concentrations [101]
and pH levels [76], among other things. Rollins et al. [86] use this model to monitor the
BGC of a type 2 diabetic. St˚ahl and Johansson [99, 98] use such a model to predict BGC
2 hours into the future in type 1 diabetics.
2.1.4 Feedback and Feedforward Control
Feedback control is a technique that has been used in chemical engineering for decades.
In feedback control, one takes measurements of some output of interest and determines
the adjustment of the process controlling that output from these measurements in order
to optimize the output in some fashion. As an example, type 1 diabetics have used this
to control their BGC for decades. If they measure their BGC and find that it is low, then
8they will ingest some carbohydrates which will increase their BGC. If their BGC is too
high, then they administer insulin to themselves. Of course, if their BGC is within their
target range, then their BGC is already optimal, and typically they will do nothing.
As for feedforward control, one adjusts the process controlling the outputs of interest
based on what he believes will happen in the near future in order to negate any undesirable
effects on the process before they can happen. Type 1 diabetics have some experience in
this as well, as they will alter their insulin prescription before they go to bed in order
to counteract the dawn phenomenon [2], which is an increase in BGC during the early
morning hours due to a rise in hormonal levels. They may also do so if they know they are
about to ingest a large quantity of carbohydrates.
Models have been created that utilize feedback and/or feedforward control. Fisher
[30] uses it to model BGC in type 1 diabetics while Salzsieger et al. [89] use it to try to
determine the optimal insulin delivery for a type 1 diabetic. Ruiz-Vela´zquez et al. [88]
use it for the same purpose in a simulation. Fisher and Teo [31] investigate three insulin
infusion programs that allows one to recover from a hyperglycemic state, one of which
uses feedback control. Tolic´ et al. [102] note that there are two sets of oscillations in the
delivery of insulin, one of which is observed over 80-150 minutes when insulin is released
by the pancreas and another over 8-15 minutes, and that delivering insulin in this manner
via feedback control could improve control over BGC. Others have used both feedback
and feedforward control in order to try to tightly control BGC. Marchetti et al. [67] use a
compartment model first derived by Hovorka et al. [49] and then revised by Wilinska et al.
[110] to implement such control.
92.1.5 Model Predictive Control
Model predictive control (MPC) is a technique used in process control to make changes
to inputs in order to minimize the deviation of a response variable from a set point. This
has become one of the most popular techniques for modeling BGC. Gillis et al. [40] use
MPC in order to deptermine a type 1 diabetic’s BGC in response to a meal. Dua et al. [23]
use MPC to determine online changes to the optimal insulin delivery rate, which in their
approach was calculated oﬄine. Nonlinear MPC has been used for glucose control during
fasting for type 1 diabetics [93], and for controlling BGC during the overnight hours. [49]
MPC and nonlinear MPC have also been used in silico, i.e. with a simulator of a type
1 diabetic’s BGC that has been approved by the FDA. [22, 56] This allows researchers to
simulate glucose data for hundreds of sample people without the need to physically collect
data. Lee et al. [59] used MPC to reduce the average BGC of an in silico type 1 diabetic
by 15-20 mg/dL. Magni et al. [66] consider MPC and nonlinear MPC in their BGC control
strategy and conclude that nonlinear MPC controls BGC better.
2.1.6 Issues
A major issue with each of these approaches is the number of inputs used in modeling.
Every study that was found in the literature only used glucose, insulin, carbohydrates
and/or exercise. While insulin will not be available for use in a noninvasive CGMS, there
are other factors that affect glucose. Stress, both physical and emotional, can affect BGC.
[46] It has also been shown that blood glucose and insulin concentrations exhibit a circadian
rhythm. [44, 106] In particular, one’s BGC tends to increase during the morning hours
before waking up due to an increase in hormones, which is known as the dawn phenomenon.
[2]
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Another major issue with many of these approaches is that they are tested on simulated
data. If an accurate model is to be found for use in a noninvasive CGMS, it must be tested
under free-living conditions. This is because the noninvasive CGMS will be used while one
is performing their daily activities, and so there will be variations observed under free-living
conditions that may not be seen in simulation.
2.1.7 Devices used in Monitoring Blood Glucose Concentrations
To monitor one’s BGC, one has typically used a CGMS that requires a sensor to
be inserted into one’s subcutaneous layer. This sensor can be uncomfortable, and there
appears to be a lag between a rise in BGC and a rise in glucose levels in the subcutaneous
layer. [38] This can be very dangerous in the presence of hypoglycemia, as one’s BGC
could be dangerously low before the CGMS predicts the onset of hypoglycemia. Finally
while the accuracy of a CGMS has increased over the past 10 years, they are still not as
accurate as glucose meters. [20, 37, 57] Several ideas have been suggested to measure one’s
BGC noninvasively: reverse iontophoresis [82], sonophoresis [55], passive diffusion [100]
and microporation [54], but only reverse iontophoresis appears to have any real chance at
commercial success.
Reverse iontophoresis is the use of electric current to pull a sample of interstitial fluid
from the skin. One such product, which was produced by Cygnus, Inc., now a part of
Johnson and Johnson (New Brunswick, NJ), was approved by the FDA in 2001 and worn
on the wrist like a watch. [80, 108] This device is calibrated by a measurement from
a glucose meter, and it can give warnings if it determines BGC to be too high or too
low, as specified by the user. However, around 10% of subjects could not use the device
due to skin irritation, and roughly 25% of the measurements from the device were found
to be inaccurate. [100] Thus the device was discontinued in 2007. Another device that
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uses reverse iontophoresis is the Symphony
TM
transdermal continuous glucose monitoring
system, produced by Echo Therapeutics (Franklin, MA). Chuang et al. [19] report that its
accuracy is on par with other FDA approved glucose meters.
There are several obstacles that must be overcome in order to successfully develop a
noninvasive CGMS. The first is that a set of noninvasive inputs must be identified that can
be accurately mapped to BGC. Not only does this include determining which inputs, but
also determining a model structure. Once this is done, steps must be taken to ensure that
these inputs are measured accurately. Given the complexity of the relationship between the
inputs and BGC, another obstacle will be to devise a method for quickly finding parameter
estimates that yield an accurate model of one’s BGC without overfitting. While parameter
estimates can be found to yield a highly accurate model for training data quickly, these
models tend to be extremely inaccurate on validation data in this work. The final obstacle
is the development of sound statistical inference methods for this model. There has been
very little research done on inference methods for the choice of model in this work, the
Wiener network. This work addresses the latter two obstacles.
In the next section, some background on current methods for modeling BGC are given
as well as their strengths and weaknesses. This includes an introduction to autoregressive
models, neural networks and Wiener networks.
2.2 Basic Approaches in Glucose Modeling
In this section many of the models used in glucose modeling are introduced. It will be
shown that many of these models can be represented by a differential equation. Methods
on fitting these models will be discussed as well as the advantages and disadvantages of
using these models.
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2.2.1 Autoregressive models
The basic autoregressive AR(p) model is written as
ym = φ0 +
p∑
i=1
φiym−i + em, (2.3)
where ym is the value of the response variable Y at timepoint m, p is the order of the model,
φi, i = 0, . . . , p are parameters to be estimated and em is a white noise disturbance term
with mean 0 and variance σ2. Here assume that the timepoints are equally spaced, i.e. the
amount of time that passes between timepoint m and timepoint m+ 1 is ∆t. This model
is frequently used when the current measurement of Y is highly correlated with previous
measurements of Y .
To see that this model can be derived from a differential equation, first consider an
AR(2) model:
ym = φ0 + φ1ym−1 + φ2ym−2 + em. (2.4)
It will be shown that Equation 2.4 can be represented by the second order differential
equation
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = c4 +
( c1
∆t2
+
c2
∆t
+ 1
)
e(t), (2.5)
where t denotes the time corresponding to timepoint m and each ci is a constant. First
one must approximate the derivatives
dy
dt
(t) and
d2y
dt2
(t). One can approximate
dy
dt
(t) with
a backward difference approximation:
dy
dt
(t) ≈ ym − ym−1
∆t
(2.6)
Now
d2y
dt2
(t) can be approximated in a similar manner:
d2y
dt2
(t) ≈
dy
dt
(t)− dy
dt
(t−∆t)
∆t
≈ ym − 2ym−1 + ym−2
∆t2
. (2.7)
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From these approximations, Equation 2.5 can be discretized and rewritten as
c1
ym − 2ym−1 + ym−2
∆t2
+ c2
ym − ym−1
∆t
+ ym = c4 +
( c1
∆t2
+
c2
∆t
+ 1
)
em (2.8)( c1
∆t2
+
c2
∆t
+ 1
)
ym −
(
2c1
∆t2
+
c2
∆t
)
ym−1 +
c1
∆t2
ym−2 = c4 +
( c1
∆t2
+
c2
∆t
+ 1
)
em (2.9)
(c1 + c2∆t+ ∆t
2)ym − (2c1 + c2∆t)ym−1 + c1ym−2 = c4∆t2 + (c1 + c2∆t+ ∆t2)em (2.10)
ym =
c4∆t
2
c1 + c2∆t+ ∆t2
+
2c1 + c2∆t
c1 + c2∆t+ ∆t2
ym−1 − c1
c1 + c2∆t+ ∆t2
ym−2 + em (2.11)
Setting φ0 =
c4∆t2
c1+c2∆t+∆t2
, φ1 =
2c1−c2∆t
c1+c2∆t+∆t2
and φ2 = − c1c1+c2∆t+∆t2 yields the AR(2)
model. To generalize, an AR(p) model can be represented with a pthorder differential
equation.
There are two steps to fitting an AR(p) model. First, one must determine the best
value of p. This can be done by calculating the partial autocorrelation function of lag p
[15]. A value of p is chosen such that the partial autocorrelation function value is near 0
for every value greater than or equal to p. Once p has been determined, the Yule-Walker
equations [15] are set up and solved to estimate the parameters as well as σ2. One can also
minimize the sum of squared residuals, which is often called the least squares objective
function, with respect to the parameters to be estimated to achieve this, as an explicit
solution can be calculated for this model.
The main advantage of using an AR model is that there exists a closed form solution
for estimating the parameters. Thus work done by Skrøvseth et al. [95] and Sparacino et
al. [96] have used AR models to predict BGC. However, determining p can be difficult at
times, since a judgment call based on a plot of the autocorrelation function is made to
determine the value of p such that the autocorrelation function of some lag q > p is not
significantly different than 0. The residuals may not exhibit white noise either. One way
to overcome this is to use an autoregressive moving average (ARMA) model.
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2.2.2 ARMA models
An autoregressive moving average ARMA(p,q) model can be written as
ym = β0 +
p∑
i=1
βiym−i +
q∑
j=1
φjem−j + em (2.12)
where ym is the value of the response variable Y at timepoint m and em is a white noise
disturbance term with mean 0 and variance σ2. Also βi, i = 1, . . . , p and γj , j = 1, . . . , q
are parameters to be estimated.
This model can also be represented by a differential equation. For example, consider
the ARMA(2,1) model
ym = β0 + β1ym−1 + β2ym−2 + φ1em−1 + em, (2.13)
This equation can be represented by the following differential equation:
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = d1 + d2
de
dt
(t) +
(
c1
∆t2
+
c2
∆t
+ 1− d2
∆t
)
e(t), (2.14)
where t denotes the time corresponding to timepoint m and each ci and di is a constant.
One can approximate
de
dt
(t) with a backward difference approximation as was done with
dy
dt
(t) in Equation 2.6. From these and Equation 2.7, one finds that this differential equation
can be approximated by
c1
ym − 2ym−1 + ym−2
∆t2
+ c2
ym − ym−1
∆t
+ ym = d1 + d2
em − em−1
∆t
+
(
c1
∆t2
+
c2
∆t
+ 1− d2
∆t
)
em (2.15)
( c1
∆t2
+
c2
∆t
+ 1
)
ym−
(
2c1
∆t2
+
c2
∆t
)
ym−1+
c1
∆t2
ym−2 = d1− d2
∆t
em−1+
( c1
∆t2
+
c2
∆t
+ 1
)
em
(2.16)
(c1 + c2∆t+ ∆t
2)ym− (2c1 + c2∆t)ym−1 + c1ym−2 = d1−d2∆tem−1 + (c1 + c2∆t+ ∆t2)em.
(2.17)
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Solving this equation for ym yields
ym =
d1∆t
2
c1 + c2∆t+ ∆t2
+
2c1 + c2∆t
c1 + c2∆t+ ∆t2
ym−1 − c1
c1 + c2∆t+ ∆t2
ym−2
− d2∆t
c1 + c2∆t+ ∆t2
em−1 + em. (2.18)
Setting β0 =
d1∆t2
c1+c2∆t+∆t2
, β1 =
2c1+c2∆t
c1+c2∆t+∆t2
, β2 = − c1c1+c2∆t+∆t2 and φ1 = −
d2∆t
c1+c2∆t+∆t2
shows equivalence to the model given in Equation 2.13.
Fitting an ARMA(p,q) model is a slightly longer process than fitting an AR model.
One can determine p using the partial autocorrelation function of lag p, as done in fitting
an AR(p) model. As for q one uses the same process as for choosing p, except that one con-
siders the correlation r∗l between em and em−l instead, which is called the autocorrelation
function of lag l. Once p and q are chosen, there are several options for fitting a model,
such as minimizing a least squares objective function [18], using the Hannan-Rissanen algo-
rithm [43, 73], and maximum likelihood estimation [12, 18]. Typically maximum likelihood
estimation is used, as one of the other algorithms is used to determine starting values for
the parameters in a maximization of the likelihood. Using maximum likelihood estimation
requires iterative techniques, such as the Levenberg-Marquardt algorithm [73, 61, 68].
Another issue with AR and ARMA models is that there may be other factors influencing
the value of the response variable. To overcome this, one may add explanatory variables to
the model. If one adds an explanatory variable to an AR model, then one is said to be using
an autoregressive exogenous variable (ARX) model. If added to an ARMA model, then
one is said to be using an autoregressive moving average model with exogenous variables
(ARMAX models).
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2.2.3 ARX models
An ARX model with a single input has the form
ym = β0 +
p∑
i=1
βiym−i +
q∑
j=1
γjxm−j + em (2.19)
where ym is the value of the response variable Y at timepoint m, xm is the value of the
independent variable X at timepoint m and em is a white noise disturbance term with
mean 0 and variance σ2. Also βi, i = 1, . . . , p and γj , j = 1, . . . , q are parameters to be
estimated.
Once again it can be shown that this model has a differential equation representation.
Consider an ARX model with with lag 2 and a single input of lag 2:
ym = β0 + β1ym−1 + β2ym−2 + γ1xm−1 + γ2xm−2 + em (2.20)
Here the corresponding differential equation is
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = d1 + d2
dx
dt
(t) + d3x(t) +
( c1
∆t2
+
c2
∆t
+ 1
)
e(t), (2.21)
where t denotes the time corresponding to timepoint m and each ci and di is a constant.
Here one can use the backward difference approximations for the derivatives of y(t) given
in Equations 2.6 and 2.7, but this cannot be done for
dx
dt
(t), as a change in the input xm
does not result in an immediate change in the output ym. Thus x(t) is replaced with xm−1
rather than xm and the backward difference approximation for
dx
dt
(t) is
dx
dt
(t) ≈ xm−1 − xm−2
∆t
. (2.22)
Thus one can approximate Equation 2.21 with
c1
ym − 2ym−1 + ym−2
∆t2
+ c2
ym − ym−1
∆t
+ ym = d1 + d2
xm−1 − xm−2
∆t
+ d3xm−1 +
( c1
∆t2
+
c2
∆t
+ 1
)
em (2.23)
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( c1
∆t2
+
c2
∆t
+ 1
)
ym −
(
2c1
∆t2
+
c2
∆t
)
ym−1 +
c1
∆t2
ym−2 = d1 +
(
d2
∆t
+ d3
)
xm−1
− d2
∆t
xm−2 +
( c1
∆t2
+
c2
∆t
+ 1
)
em (2.24)
(c1 + c2∆t+ ∆t
2)ym − (2c1 + c2∆t)ym−1 + c1ym−2 = d1∆t2 + (d2∆t+ d3∆t2)xm−1
− d2∆txm−2 + (c1 + c2∆t+ ∆t2)em (2.25)
ym =
d1∆t
2
c1 + c2∆t+ ∆t2
+
2c1 + c2∆t
c1 + c2∆t+ ∆t2
ym−1 − c1
c1 + c2∆t+ ∆t2
ym−2
+
d2∆t+ d3∆t
2
c1 + c2∆t+ ∆t2
xm−1 − d2∆t
c1 + c2∆t+ ∆t2
xm−2 + em (2.26)
Setting β0 =
d1∆t2
c1+c2∆t+∆t2
, β1 =
2c1+c2∆t
c1+c2∆t+∆t2
, β2 = − c1c1+c2∆t+∆t2 , γ1 =
d2∆t+d3∆t2
c1+c2∆t+∆t2
, and
γ2 = − d2∆tc1+c2∆t+∆t2 will show equivalence.
Fitting an ARX model is similar to fitting an AR model, as one can use either the
Yule-Walker equations or least squares once p has been determined. While this model can
take into account external factors that influence the response variable, Nelles [73] reports
that if the residuals from fitting an ARX model do not appear to be white noise, then the
parameter estimates may be biased. While there exist techniques to fit an ARX model
that deal with the issue of bias [73], one may choose to fit an ARMAX model to overcome
this problem instead.
2.2.4 ARMAX models
An ARMAX model can be written as
ym = β0 +
p∑
i=1
βiym−i +
q∑
j=1
γjxm−j +
r∑
k=1
φkem−k + em (2.27)
where ym is the value of the response variable Y at timepoint m, xm is the value of the
independent variable X at timepoint m, and em is a white noise disturbance term with
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mean 0 and variance σ2. Also βi, i = 1, . . . , p, γj , j = 1, . . . , q, and φk, k = 1, . . . , r are
parameters to be estimated.
To show that an ARMAX model can be represented with a differential equation, con-
sider an ARMAX model with lag 2, a single input of lag 2 and an error term with lag
1:
ym = β0 + β1ym−1 + β2ym−2 + γ1xm−1 + γ2xm−2 + φ1em−1 + em (2.28)
This model is equivalent to the following second order plus lead time differential equation
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = d1 + d2
dx
dt
(t) + d3x(t) + d4
de
dt
(t) +
(
c1
∆t2
+
c2
∆t
+ 1− d4
∆t
)
e(t),
(2.29)
where t denotes the time corresponding to timepoint m and each ci and di is a constant.
One can approximate the derivatives in this differential equation as before and solve for
ym. Setting β0 =
d1∆t2
c1+c2∆t+∆t2
, β1 =
2c1+c2∆t
c1+c2∆t+∆t2
, β2 = − c1c1+c2∆t+∆t2 , γ1 =
d2∆t+d3∆t2
c1+c2∆t+∆t2
,
γ2 = − d2∆tc1+c2∆t+∆t2 , and φ1 = −
d4∆t
c1+c2∆t+∆t2
will show equivalence.
Determining parameter estimates for an ARMAX model is similar to that of an ARMA
model. Nelles [73] outlines two other apporaches for finding optimal parameters. For both
approaches, an ARX model is first fit to determine starting parameters. In the first ap-
proach, a nonlinear optimization technique, such as the Levenberg-Marquardt algorithm,
utilizes these starting parameters to determine the parameter estimates. In the other
approach, which is also called extended least squares [62], the residuals from the ARX
model are calculated and then the ARMAX model is fit using the ARX model residuals
as estimates of em. Afterwards an ARX model is fit with the fitted ARMAX model resid-
uals. These two models are refit using the other’s residuals until the parameter estimates
converge. While this model deals with the possible problems of the residuals exhibiting
nonconstant variance and outside factors that are influencing the response variable, it does
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not allow for possible interactions between inputs. This can be overcome by using a NAR-
MAX model, which is a nonlinear autoregressive moving average model with exogenous
inputs.
2.2.5 NARMAX models
NARMAX models have rarely been used for glucose modeling. St˚ahl and Johannsen[99]
use it in their comparison of models for glucose modeling. While a NARMAX model can
have a very general form [78], here a NARMAX model with w inputs will be written as
ym = f(ym−1, . . . , ym−p, x1,m−1, . . . , x1,m−q, x2,m−1, . . . , xw,m−q, em−1, . . . , em−r) + em,
(2.30)
where f is a function that is nonlinear in the inputs, but linear in the previous values of y
and em is a white noise disturbance term with mean 0 and variance σ
2. While NARMAX
models are nonlinear in the inputs, they are linear in the parameters. An example with 2
inputs and their interaction is
ym =β0 + β1ym−1 + β2ym−2 + γ11x1,m−1 + γ12x1,m−2 + γ21x2,m−1 + γ22x2,m−2
+ δ1x1,m−1x2,m−1 + δ2x1,m−2x2,m−2 + φ1em−1 + em (2.31)
A NARMAX model defined in this way can also be represented by a differential equation:
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = d1 + d2
dx1
dt
(t) + d3x1(t) + d4
dx2
dt
(t) + d5x2(t)
+ d6
dx1x2
dt
(t) + d7x1(t)x2(t) + d8
de
dt
(t) +
(
c1
∆t2
+
c2
∆t
+ 1− d8
∆t
)
e(t). (2.32)
The derivatives for the outputs and residuals may be approximated as done in previous
derivations. While there are multiple inputs, xi(t) is replaced in the differential equation
with xi,m−1 since a change in the input cannot immediately impact the output, and dxidt (t)
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for i = 1, 2 are approximated as in Equation 2.22, i.e.
dxi
dt
(t) ≈ xi,m−1 − xi,m−2
∆t
. (2.33)
With these approximations for the derivatives, one can solve for yt. By setting β0 =
d1∆t2
c1+c2∆t+∆t2
, β1 =
2c1+c2∆t
c1+c2∆t+∆t2
, β2 = − c1∆tc1+c2∆t+∆t2 , γ11 =
d2∆t+d3∆t2
c1+c2∆t+∆t2
, γ12 = − d2∆tc1+c2∆t+∆t2 ,
γ21 =
d4∆t+d5∆t2
c1+c2∆t+∆t2
, γ22 = − d4∆tc1+c2∆t+∆t2 , δ1 =
d6∆t+d7∆t2
c1+c2∆t+∆t2
, δ2 = − d6∆tc1+c2∆t+∆t2 , and
φ1 = − d8∆tc1+c2∆t+∆t2 , equivalence between the resulting equation and the NARMAX model
is shown.
Like an ARMAX model, a NARMAX model must be fit via iterative methods due to
the recursive definition of the residuals. While the NARMAX model compensates for many
of the shortcomings of the other autoregressive models, it has weaknesses. Rollins et al. [86]
note that if inputs are highly correlated, then the model matrix is ill-conditioned, which
can cause large variance estimates for the parameters, and thus for predictions. Another
issue is the possibility of overfitting.
2.2.6 Wiener networks
The Wiener network has a powerful structure for modeling nonlinear dynamic systems.
A block diagram with p inputs and one output is given in Figure 5.1. Each input xi is first
passed through a dynamic linear block, denoted g(xi) and converted into its corresponding
dynamic variable vi. For this work the following second-order-plus-lead with dead time
differential equation will be used:
τ2i (t,xi)
d2vi
dt2
(t) + 2τi(t,xi)ζi(t,xi)
dvi
dt
(t) + vi(t,xi) = τai(t,xi)
dxi
dt
(t)xi(t− θi), (2.34)
where τi is a time constant, τai is a lead parameter, ζi is a damping coefficient, and θi
denotes dead time. For simplicity, assume that the dynamic parameters are time and
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Figure 2.1 A graphical representation of the Wiener model used in Rollins
et al. [86].
x1
x2
yˆf(v)
v
v1
v2
vp
g(x1)
g(x2)
g(xp)xp
...
space invariant, i.e. τi(t,xi) = τi, τai(t,xi) = τai and ζi(t,xi) = ζi. Also vi(t,xi) will be
written as vi(t) henceforth. The vectors τ , τa, and ζ will denote all time constants, lead
parameters and damping coefficients, respectively.
Since there does not exist a solution to this differential equation, a recursive definition
for vi(t) must be found. To this end, a backward difference approximation to
dvi
dt
(t) will
be used. Then, as done for Equations 2.6 and 2.7,
dvi
dt
(t) ≈ vi(t)− vi(t−∆t)
∆t
. (2.35)
and
d2vi
dt2
(t) ≈ vi(t)− 2vi(t−∆t) + vi(t− 2∆t)
∆t2
(2.36)
Furthermore, as for ARMAX and NARMAX models, a step change in the input does
not immediately affect the dynamic variable or the output. Thus, in determining vi(t),
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xi(t) is replaced by xi(t − ∆t). This substitution is also used in the backward difference
approximation of dxidt (t). By substituting Equations 5.2 and 5.3 into Equation 5.1:
vi(t) =
2τ2 + 2τζ∆t
τ2 + 2τζ∆t+ ∆t2
vi(t−∆t)− τ
2
τ2 + 2τζ∆t+ ∆t2
vi(t− 2∆t)
+
∆t(τa + ∆t)
τ2 + 2τζ∆t+ ∆t2
xi(t− θi −∆t)− τa∆t
τ2 + 2τζ∆t+ ∆t2
xi(t− θi − 2∆t) (2.37)
The resulting vi’s are then passed through a static nonlinear block, denoted f(v) in
Figure 5.1. The function f is typically a nonlinear function with respect to the inputs. For
example, denoting x = (x1, . . . , x11), Rollins et al. [86] use
f(x) = a0 +
11∑
i=1
aixi +
11∑
j=1
bjx
2
j +
10∑
k=1
11∑
l=k+1
ck,lxkxl. (2.38)
Let a, b, and c denote the vectors corresponding to all linear, quadratic and interaction
parameters. They will be collectively referred to as the static parameters. Replacing the
xi with vij and denoting the fact that the vi’s depend on xi, the final resulting model is
f(t,X) = a0 +
11∑
i=1
aivi(t) +
11∑
j=1
bjv
2
j (t) +
10∑
k=1
11∑
l=k+1
ck,lvk(t)vl(t) + (t), (2.39)
where X = [x1 x2 · · · x11] and (t) is a normally distributed error term with mean 0
and variance σ2. The residuals (t1) and (t2), t1 6= t2 are also assumed to be independent
of one another.
Since the errors are assumed to be independent and identically normally distributed
with mean 0 and constant variance, typically a least squares objective function is minimized
to find parameter estimates. This must be done with iterative methods due to the dynamic
paramters. There are several advantages to using a Wiener network. One is that the
dynamic parameters have phenomenological meaning. For example, the residence time of
input i can be estimated as 2τiζi. Second, its flexible structure allows it to model many
different types of phenomena, including models where multiple outputs are needed. The
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final advantage is that inputs are allowed to have different dynamics. If one chooses to use
carbohydrates and protein consumption in modeling BGC, then given that the pathway
for protein to be converted to glucose is much longer than that of carbohydrates, it makes
sense for the residence time of protein to be greater than that of carbohydrates. One
disadvantage is that the number of parameters can become very large depending on the
number of inputs and the choice of function for the static nonlinear block.
2.2.7 Neural Networks
The last model to be introduced here, the neural network, has a different structure than
the previous models. Like compartment models, they can handle any number of inputs or
outputs. A neural network can be used for either regression or classification, but the focus
here will be on regression. A figure of a neural network is given in Figure 2.2. Here we will
follow the notation from Hastie et al. [47]. Given a set of inputs X, for i = 1, . . . , n, one
can define a neural network with p inputs, m hidden nodes and q outputs. Let Zi denote
the ithhidden node and Yj denote the j
thoutput. Then
Z1 =σ(α10 + α11X1 + · · ·+ α1pXp)
...
Zm =σ(αm0 + αm1X1 + · · ·+ αmpXp) (2.40)
and
Y1 =g1(β10 + β11Z1 + · · ·+ β1mZm)
...
Yq =gq(βq0 + βq1Z1 + · · ·+ βqmZm), (2.41)
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Figure 2.2 A graphical representation of a neural network with three inputs
(Xl), two hidden nodes (Zi) and three outputs (Yj).
X1 X2 X3
Z1 Z2
Y1 Y2 Y3
where σ and gj for j = 1, . . . , q are functions. For σ, a popular choice is
σ(v) = (1 + e−v)−1, (2.42)
though any real-valued function can be used. As for gj , the identity function is typically
used if the neural network is used for regression. Here the αi’s and βj ’s are parameters to
be estimated.
A neural network is typically fit using a least squares objective function and the back-
propagation algorithm. This algorithm uses the chain rule and a steepest descent step
to update the parameters. Typically this algorithm is not fit to convergence due to the
possibility of overfitting.
Due to the flexibility in the choice of σ and gj , the neural network can be used as a
model for a variety of situations. However, Rollins et al. [87] argue that an artificial neural
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network can be used to find a model with a low error sum of squares on one subset of the
data, but its performance on another subset of data may be poor due to extrapolation or
changing dynamics.
Due to its advantages mentioned above and the disadvantages of other models, the
Wiener network will be used for modeling BGC in this work. However, there are some
difficulties that must be addressed. One is finding a methodology for fitting a Wiener
network that avoids overfitting. While iterative methods can be used to find parameter
estimates that yield a highly accurate model to the training data, typically this model will
fit validation data poorly. Given this choice of function for the static nonlinear block, there
are some parameters that are linear in the model. This is said to be a separable model,
which allows for specialized algorithms to be used, such as those by Barham and Drane [4]
and Golub and Pereyra [42]. However, these algorithms have also tended to badly overfit
training data.
2.3 Forecasting Intervals
Another goal of this research is to be able to predict BGC at a given point in time in
the future. Typically every model discussed thus far is used to predict BGC at the current
time. However, several studies have been done to predict future BGC as well, and a wide
variety of models have been used for this purpose. Sparacino et al. [96], Reifman et al.
[83], and Gani et al. [36] use autoregressive models to predict BGC up to 90 minutes in the
future. Eren-Oruklu et al. [25] utilize ARMA and ARMAX models to detect hypoglycemia
30 minutes into the future. Pappada et al. [77] use neural networks to predict BGC in type
1 diabetics up to 3 hours into the future. Rollins et al. [86] use a Wiener network in order
to develop a model that predicts BGC in type 2 diabetics up to 90 minutes ahead of time.
Such models could be referred to as k-steps ahead prediction (KSAP) models.
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In econometrics, predicting the level of some variable in the future is called forecasting.
Chatfield [16, 17] gives a fairly comprehensive review of current methods for calculating
(1−α)100% prediction intervals when forecasting the value of the response variable at some
time in the future. For this work, such an interval will be denoted a (1− α)100% forecast
interval. The rest of this section is devoted to the various techniques used to calculate
forecast intervals.
2.3.1 Intervals Based on Theory
In some cases, one can derive a formula for the variance of the response variable Yt,
denoted σ2 for use in a forecast interval. This is the case for linear regression, and as will
be shown, many of the autoregressive models described in Section 2.2. In this approach, a
(1−α)100% forecast interval for the value of the response variable at k timesteps into the
future can be calculated by
yˆt+k ± zα/2σˆk
√
1 + ck, (2.43)
where σˆk is the estimate of the square root of the variance of Yt+k found from fitting the
model and ck is some constant such that Var(Yt+k − yˆt+k) = σ2k(1 + ck).
One model where σ2k can be determined is an AR(1) model. As given by Madsen et al.
[64], the AR(1) model, written without an intercept, is yt = φyt−1 + t, where the residuals
are assumed to be independent and identically distributed NOR(0,σ2). For this model
k = 1, or a 1-step ahead prediction model, since yt is one timestep ahead of yt−1. One can
determine Var(Yt) by first noting that, according to the AR(1) model, yt−1 = φyt−2 + t−1,
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yt−2 = φyt−3 + t−2, etc., which implies that
yt = φ(φyt−2 + t−1) + t
= φ2yt−2 + φt−1 + t
= φ2(φyt−3 + t−2) + φt−1 + t
= φ3yt−3 + φ2t−2 + φt−1 + t
...
=
∞∑
i=0
φit−i. (2.44)
From this, one finds that
Var(Yt) =
∞∑
i=0
φ2iσ2
=
σ2
1− φ2 . (2.45)
In this situation, Var(Yt) can be estimated by replacing φ and σ
2 with φˆ and σˆ2 found
from fitting the model. One can show that for an ARX(1,z) model, where z is any integer
and the exogenous variable is assumed to be measured without error, Var(Yt) is the same
as that for an AR(1) model.
An ARMA(1,1) model is another model where a formula for the variance can be derived.
The derivation is similar as before, as the goal is to reduce the model to an infinite sum of
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residuals. Again k = 1 and for convenience the intercept will be set to zero. This yields
yt = αyt−1 + φt−1 + t
= α(αyt−2 + φt−2 + t−1) + φt−1 + t
= α2yt−2 + αφt−2 + (α+ φ)t−1 + t
= α2(αyt−3 + φt−3 + t−2) + αφt−2 + (α+ φ)t−1 + t
= α3yt−3 + α2φt−3 + α(α+ φ)t−2 + (α+ φ)t−1 + t
...
= t +
∞∑
i=1
αi−1(α+ φ)t−i (2.46)
Now Var(Yt) is easy to calculate:
Var(Yt) = σ
2 +
∞∑
i=1
α2(i−1)(α+ φ)2σ2
= σ2
(
1 +
(α+ φ)2
1− α2
)
. (2.47)
Again parameter estimates σˆ2, αˆ, and φˆ are substituted into the equation for Var(Yt) to
estimate it. As with the AR(1) and ARX(1,1) models, adding an exogenous input that
is measured without error does not affect the variance. Hence Var(Yt) for an ARMAX
model with one input, regardless of the lag on that input, is the same as Var(Yt) for an
ARMA(1,1) model. Unfortunately this approach only works if the model assumptions
appear to be valid, which does not always happen in practice. Furthermore, deriving the
variance can be extremely difficult for other models.
2.3.2 Empirical Methods
If it appears that the residuals do not exhibit symmetry, then the forecast interval given
in Equation 2.43 will exhibit less than nominal coverage. One method for dealing with this
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issue is the use of empirical methods. The typical empirical method for the values ±zα/2σˆe
are replaced with the 100αth and the 100(1−α)th percentiles of the empirical distribution
of the residuals found from fitting a model to a training set. This method requires very
little computational power, but it may miss trends in the data, particularly if the data
used in fitting the model is not a good representation of the true population. Chatfield
[16] notes that two other approaches have been mentioned in the literature.
In the first approach, which is given in Gilchrist [39], the standard deviation of a
KSAP model is estimated with the standard deviation of the k-steps ahead errors. Let the
standard deviation of the errors from the k-steps ahead prediction model be denoted sk.
Thus the (1−α)100% forecast interval in this approach is yˆt+k ± zα/2sk, where zα/2 is the
1− α/2 percentile of a standard normal distribution. If the number of samples used to fit
the KSAP model is small, the (1 − α/2) · 100th percentile of a t distribution with n − 2
degrees of freedom could be used in place of zα/2. Chatfield [16] reports that this method is
unreliable for small n and large k. This method could also perform poorly if the residuals
are not a random sample from a symmetric distribution.
The second approach is given in Williams and Goodman [111]. In their approach,
they use the first 24 observations to fit a model that predicts the number of business main
telephones in service on the last day of a month in a city in Michigan, and then use the model
to predict the number of business main telephones in service each month for 18 months
into the future. After collecting the errors from this model, the first observation from the
second set is added to the first set, and then a model is fit to the first 25 observations. An
18 month forecast is again calculated, and the errors are collected. This is repeated for
the remainder of the dataset. From their work, the absolute values of the observed errors
appeared to follow a gamma distribution as opposed to a standard normal distribution.
The resulting prediction intervals from the gamma distribution appeared to have coverage
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much closer to the (1 − α)100% rate than those calculated from the residuals and the
standard normal distribution. This approach may not work well if a closed form solution
for the parameter estimates cannot easily be obtained, as iterative methods may cause
this approach to require a large amount of computation. This is particularly true if the
model of interest has many parameters, which requires a larger dataset to fit the initial
model. For Williams and Goodman, their model only contained 14 parameters, and thus
they could begin forecasting with a dataset with only 24 observations.
2.3.3 Bootstrap Methods
The bootstrap method is another option for constructing forecast intervals when the
residuals appear to be asymmetric. One of the most widely used methods for calculating
forecast intervals, this approach is used when the true distribution of the residuals is
unknown or when there is only a small amount of data available for fitting a model. For
this approach, one fits a model to obtain residuals {e1, e2, . . . en}, where n is the number
of observations used to fit the data. A random sample {e∗1, e∗2, . . . e∗n} of these residuals is
drawn with replacement where each residual is equally likely to be drawn. With many such
samples, one can estimate the standard error of the residuals in order to perform inference.
Two books that give a solid introduction to this topic are Efron and Tibshirani [24] and
Hjorth [48].
Several studies on the bootstrap have been done in the literature pertaining to KSAP
modeling. Veall [107] gives a fairly comprehensive review of computation methods for
econometric models, including the bootstrap. Freedman and Peters [34] use the bootstrap
to compute forecast intervals for the prices for capital, labor and energy in 1995 based on
historical information from 1948-1971. Several papers that deal with the bootstrap in the
presence of an autoregressive model include Findley [29] and Stine [97].
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2.3.4 Forecasting Abnormal Glucose Levels
Such a forecast interval could be utilized to assess the risk of hyperglycemia or hy-
poglycemia before it occurs. This would allow one to take action that could completely
prevent abnormal BGC. Some devices that currently offer to alarm the user of impend-
ing hyperglycemia or hypoglycemia include the Minimed Guardian R© REAL-Time System
(Medtronic Minimed, Northridge, CA) [9], the SEVEN R© PLUS System (DexCom, Inc.
San Diego, CA) [3] and the 5-day FreeStyle Navigator (Abbott Laboratories, Abbott Park,
IL) [109]. Both the Minimed Guardian R© REAL-Time System and the 5-day FreeStyle
Navigator can alarm the user up to 30 minutes before a possible episode of abnormal
BGC. Wolpert [112] and Mastrototaro et al. [69] warn that a current limitation of this
technology is the possibility of too many false alarms. While those whose main concern is
hypoglycemia may be tolerant of these false alarms, those who are not as concerned may
turn off this feature, which could have dire consequences for the user should they become
hypoglycemic.
Several studies have considered implementing an alarm that could warn the user of im-
pending abnormal BGC. Bequette [7] reviews several techniques for implementing such an
alarm. He reports that the most common method for predicting future episodes of hyper-
glycemia or hypoglycemia is what he calls a “linear projection.” In this linear projection,
the simple linear regression model
y(t) = β0 + β1t+ , (2.48)
where y(t) is the observed BGC at time t, the residuals  are independent and identically
normally distributed with mean 0 and variance σ2, and β0 and β1 are parameters to be
estimated, is fit to a set of previous BGC measurements. From this model, one can use
least squares theory to construct (1 − α)100% forecast intervals for BGC at an amount
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of time into the future. If the predictions and/or the forecast intervals from the linear
projection suggest that there is a high probability of hypoglycemia or hyperglycemia in the
near future, then an alarm will warn the user of such a possible occurrence. Brauker [11]
suggest a similar approach to forecasting BGC, while Noujaim et al. [75] investigate how
accurate a CGMS must be in order to accurately institute such a method for forecasting
BGC. One disadvantage of this approach is that an alarm may be sounded just before
one’s BGC has stabilized on its own. This could occur when previous measurements of
BGC indicate a quadratic relationship with time rather than a linear relationship. Another
disadvantage of this approach is that it may not work well when one’s BGC has a large
variance. This could cause an inaccurate forecast of BGC, which could either cause a false
alarm to sound or an episode of future hypoglycemia or hyperglycemia to occur undetected.
For example, if one attempts to forecast BGC soon after a meal, then the shape of the
BGC data may be curved, as BGC typically rises soon after a meal and then falls. Fitting a
regression to this will cause the slope of the fitted regression line to be grossly inaccurate.
This causes the forecast to be inaccurate, and so the likelihood of a false alarm or the
failure of an alarm to sound to warn the user of abnormal BGC increases.
There are other approaches being taken to forecast BGC. These methods have focused
on hypoglycemia, as the risk of death is much greater for one who is hypoglycemic as
opposed to one who is hyperglycemic. Eren-Oruklu et al. [25] use ARMA and ARMAX
models to predict hypoglycemic episodes 30 minutes prior to their occurrence. Hughes
et al. [50] develop two algorithms that alter the infusion rate of insulin when the risk
of hypoglycemia is high. These algorithms also try to prevent rebound hyperglycemia,
which can happen if the amount of blood insulin concentration becomes too low when one
decreases it in order to treat hypoglycemia. It also warns the user so that they may take
further action, such as ingesting some carbohydrates to prevent the hypoglycemic episode.
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This would be of great use to type 1 diabetics, who could receive an alarm while sleeping
to warn them of future hypoglycemia.
Another challenge in using the Wiener network that will be used in this work to predict
BGC is the lack of statistical inference methods. Since a Wiener network is a dynamic non-
linear model, even calculating a (1−α)100% prediction interval with the desired coverage is
difficult. An added difficulty is that we would like to use this model to assist in predicting
future BGC. The final goal of this work is to construct approximate (1− α)100% forecast
intervals to be used to forecast future BGC. In order to do this, the Wiener network will
be modified so that it can accurately predict BGC at a time point in the future. The
model structure of this modified Wiener network will be exploited in order to construct
the approximate forecast intervals. It is hoped that such a forecast interval could be used
to predict future episodes of hypoglycemia or hyperglycemia.
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CHAPTER 3. AN ALGORITHM FOR OPTIMALLY FITTING A
WIENER MODEL
A paper to be submitted to Computers and Chemical Engineering
Lucas P. Beverlin, Derrick K. Rollins, Kaylee Kotz, Nisarg Vyas, David Andre, Greg
Welk, and Warren Franke
Abstract
The purpose of this work is to present a new methodology for fitting Wiener networks
to datasets with a large number of variables for use in a device that noninvasively monitors
one’s blood glucose concentration. Wiener networks have the ability to model a wide range
of data types and their structures can yield parameters with phenomenological meaning.
There are several challenges to fitting such a model: model stiffness, the nonlinear nature
of a Wiener network, possible overfitting and the large number of parameters inherent to
large input sets. To overcome these challenges, a methodology for fitting Wiener networks
is presented that utilizes its structure. In this methodology, dynamic parameters are first
identified by utilizing an intelligent grid search, and the resulting dynamic variable is used
in the estimation of static parameters. This methodology is used to fit Wiener networks
to predict blood glucose concentration in 24 subjects. Models for five of these subjects
compare favorably to Wiener networks fit manually to the same data using the Solver
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add-in for Microsoft Excel R©.
3.1 Introduction
Wiener networks are widely used in modeling complex nonlinear systems. These net-
works have been used to model a wide range of data, such as gas concentrations [101],
blood glucose concentrations [86], and pH levels [76], and their structure can yield param-
eters with phenomenological meaning [86]. In this work, Wiener networks are used to first
convert inputs into their corresponding dynamic responses and then to pass these dynamic
responses through a linear regression function to obtain the fitted output response. The
parameters needed to convert the inputs into dynamic responses are referred to as dynamic
parameters and the parameters of the linear regression function as static parameters.
The estimation of these parameters can be challenging, as the behavior of these networks
can be highly nonlinear in the dynamic parameters. Since the Wiener network is a nonlinear
model, there is typically no closed form solution for finding optimal parameter estimates.
Hence iterative methods must be used to find parameter estimates. Several such iterative
methods are given in Bates and Watts [6], Seber and Wild [90], Nelles [73] and Nocedal and
Wright [74]. The number of parameters, which can be large, also increases rapidly as inputs
are added. Given that Wiener networks utilize differential equations to convert an input
into a dynamic response, stiffness, which is a situation where the derivative in a differential
equation increases or decreases rapidly while the solution to the differential equation does
not [26, 58], is another concern. This phenomenon causes an algorithm to take very small
steps (i.e. progress slowly) in order to reach an optimal solution. Overfitting, a phenomenon
where the model fits the data used to find the model well, but fits an independent dataset
poorly, can also be a major issue.
The basic purpose of this article is to present a new methodology for fitting Wiener
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networks to large input datasets in order to build subject-specific models in a device that
noninvasively predicts blood glucose concentration (BGC) in people who are not insulin
dependent that overcomes the challenges described in the previous paragraph. By fitting
subsets of the parameters iteratively, we can deal with a large number of parameters and
their nonlinearity, as numerical instability in the next iteration is less likely when fitting
a subset of the parameters. During optimization, intelligent grid searches will be used to
overcome stiffness. To avoid overfitting, we will utilize what is called “supervised learning”
in the statistics literature[47, 51]. In supervised learning, the dataset is broken up into a
training set, a validation set, and a test set. The model is fit to the training set with the
validation set used to evaluate the fitted model against an independent dataset to guard
against overfitting. The test set is scrutinized at the end of the optimization process to
further evaluate if overfitting has occurred.
The proposed methodology is presented with the following outline. First a detailed
description of the Wiener network with multiple inputs and a single output is given to
establish the problem context. In Section 3 the details of the methodology are presented
and an example is given to illustrate the algorithm in Section 4. Finally concluding remarks
and some ideas for future work are given in the last section.
3.2 The Wiener Network
The Wiener network has a powerful structure for modeling nonlinear dynamic systems.
A block diagram with p inputs and one output is given in Figure 5.1. Each input x is first
passed through a dynamic linear block, denoted g(xi) and converted into its corresponding
dynamic variable vi. In Rollins et al. [86], the following second-order-plus-lead with dead
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Figure 3.1 A graphical representation of the Wiener model used in Rollins
et al. [86].
x1
x2
yˆf(v)
v
v1
v2
vp
g(x1)
g(x2)
g(xp)xp
...
time differential equation is used:
τ2i (t,xi)
d2vi
dt2
(t,xi)+2τi(t,xi)ζi(t,xi)
dvi
dt
(t,xi)+vi(t,xi) = τai(t,xi)
dxi
dt
(t−θi)+xi(t−θi),
(3.1)
where τi is a time constant, ζi is a damping coefficient, τai is a lead coefficient, θi denotes
dead time and t is time. For simplicity, assume that the dynamic parameters are time and
space invariant, i.e. τi(t,xi) = τi and ζi(t,xi) = ζi. Also vi(t,xi) will be written as vi(t)
henceforth. The vectors τa, τ and ζ will denote all lead coefficients, time constants and
damping coefficients, respectively.
In order to calculate vi(t), a recursive definition for vi(t) must be found since there is
no solution to this differential equation. This can be found by using a backward difference
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approximation for the derivatives in Equation 5.1:
dvi
dt
(t) ≈ vi(t)− vi(t−∆t)
∆t
(3.2)
and
d2vi
dt2
(t) ≈ vi(t)− 2vi(t−∆t) + vi(t− 2∆t)
∆t2
(3.3)
It should be noted that since an instantaneous change in xi at time t cannot result in an
instantaneous change in vi at time t under this structure, one must approximate xi(t− θi)
with xi(t− θi −∆t) and dxidt (t) with xi(t− θi −∆t) and xi(t− θi − 2∆t):
dxi
dt
(t) ≈ xi(t− θi −∆t)− xi(t− θi − 2∆t)
∆t
. (3.4)
By substituting Equations 5.2 - 5.4 into Equation 5.1:
vi(t) =
2τ2i + 2τiζi∆t
τ2i + 2τiζi∆t+ ∆t
2
vi(t−∆t)− τ
2
i
τ2i + 2τiζi∆t+ ∆t
2
vi(t− 2∆t)
+
τai∆t+ ∆t
2
τ2i + 2τiζi∆t+ ∆t
2
xi(t−∆t− θi)− τai∆t
τ2i + 2τiζi∆t+ ∆t
2
xi(t− 2∆t− θi)
(3.5)
The resulting vi’s are then passed through a static nonlinear block, denoted f(v) in
Figure 5.1. The function f is typically a nonlinear function with respect to the vi’s. For
example, Rollins et al. [86] uses 11 inputs and the following function for the static nonlinear
block:
f(v1(t), . . . , v11(t)) = a0 +
11∑
i=1
aivi(t) +
11∑
j=1
bjv
2
j (t) +
10∑
k=1
11∑
l=k+1
ck,lvk(t)vl(t). (3.6)
In this work, the quadratic and second-order interaction terms will be omitted, in order to
reduce the parameterization of the model. Three of the inputs used by Rollins et al. were
also removed to further reduce parameterization. Thus the static block is represented by
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a linear regression model. Hence the final resulting model is
y(t) = a0 +
8∑
i=1
aivi(t) + (t). (3.7)
where (t) is a normally distributed error term with mean 0 and variance σ2. These error
terms are assumed to be independent of one another. Finally let a denote the vector
corresponding to all linear static parameters. They will be collectively referred to as the
static parameters.
3.3 The Parameter Estimation Algorithm
In this section the featured algorithm to fit the Wiener network given in the previous
section will be described. Following Rollins et al. [86], the objective of this modeling
problem is to maximize the true but unknown correlation coefficient ρy,yˆ between the
measured and fitted BGC, which is estimated by
rfit =
∑n
i=1(yi − y¯)(yˆi − ¯ˆy)√∑n
i=1(yi − y¯)2
√∑n
i=1(yˆi − ¯ˆy)2
, (3.8)
where n is the number of observations used in fitting the model. More specifically, under
this objective a model is declared useful if and only if
ρy,yˆ > 0. (3.9)
The meaning of this criterion is that predictions of BGC from the model decrease and
increase with measured BGC beyond some degree of mere chance, i.e. there is true positive
correlation. Notwithstanding, the closer this value is to the upper limit of 1, the more
useful the model. Therefore, to achieve this objective, one seeks to identify a model with a
sufficiently large value of rfit. To this end, the data are separated into three sets: a training
set, a validation set, and a test set. The training set is used to build the model and the
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validation set is used to evaluate the model against data that are not directly used by the
optimization process to estimate the model parameters. The test set is used to ensure that
the model accurately predicts BGC on an independent data set.
While rfit could be used as a function of the parameters to be maximized, its highly
complex mapping of the parameters into the response space of rfit makes this impractical.
Thus in order to identify a model with as large a value of rfit as possible, one might minimize
the error sum of squares (SSE) with respect to the parameters instead, i.e.
Maximize rfit by minimizing SSE
Θ
=
n∑
i=1
(yi − yˆi)2
Subject to: ζi > 0, τi > 0, θi ≥ 0 ∀i, (3.10)
where Θ is a vector representing the estimated dynamic and static parameters τ , ζ, τa,θ,a
and n is the number of observations in the training set. For simple linear regression,
minimizing SSE will yield the same parameter estimates as maximizing rfit. While this is
not always guaranteed in nonlinear regression, experimental evidence supports the notion
that as SSE decreases, rfit increases. [86] A major advantage of minimizing SSE is that there
exist many algorithms for minimizing it. Specialized algorithms for the minimization of
SSE include the Gauss-Newton algorithm [45, 65] and the Levenberg-Marquardt algorithm
[61, 68, 65]. Other algorithms used for this purpose include the BFGS algorithm [13, 32,
41, 94] and the conjugate gradient algorithm [74]. While these algorithms will succeed in
finding a model with a large rfit on the training set if allowed to run to convergence, this
typically results in a badly overfit model, in that the value of rfit found for this model on a
test set is very low. To combat overfitting, supervised learning can be used in conjunction
with these methods. However, this was found to result in a poor fit for training, validation
and test sets if all parameters are used simultaneously. Model fitting was found to be slow
if subsets of the parameters were fit during supervised learning. If this algorithm is to be
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used in a device that will build a model of one’s BGC to be used on data not used to build
the model, a different approach must be sought.
While determining a model whose rfit is as large as possible should result in finding a
useful model, the model could still exhibit significant bias. Significant bias could cause the
predictions of BGC to indicate normal BGC levels when in fact they may be dangerously
high or low. Thus a secondary criterion on the absolute difference between yi and yˆi is
used for model assessment. This measure of accuracy, denoted the average absolute error
(AAE), is
AAE =
∑n
i=1 |yi − yˆi|
n
, (3.11)
where n is the number of measurements used in the calculation of this statistic. As AAE
decreases, accuracy is judged to increase. In the presence of model bias, rfit can be large
despite a large AAE. Thus eliminating bias from the model improves the accuracy of the
model.
Thus, in addition to a sufficiently large rfit value for the training set and a sufficiently
large correlation on the validation set, denoted rval, an acceptable model must also have
a relatively small value of AAE in training. Achieving a relatively small value of AAE in
validation is not necessary if a large rfit value is observed from the model on both sets. If a
model achieves a high rfit as demonstrated in training then high accuracy in the validation
set can be obtained with effective feedback correction or feedback control to reduce or
eliminate bias.
For simplicity, we will assume that θi is fixed for every i and that τai = 0. From
experience, the improvement in model performance that can be achieved by including θi
and τai as estimable parameters appears to be small in comparison to the increase of the
algorithm’s speed with 22 fewer parameters to estimate. Finally, in order to maintain
stability in the differential equation, τi and ζi must be greater than 0. For more details on
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these dynamic parameters, see Seborg et al. [91]
Now we present the algorithm, which will fit a Wiener network model to each subject.
The main steps of the algorithm are given, with a detailed explanation of what happens
in the algorithm given below it. Pseudocode for this algorithm is given in the Appendix.
Let y denote the observed BGC in the dataset, yTr the observed BGC in the training set
and yV a the observed BGC in the validation set. These superscripts will be used to denote
training and validation sets throughout this section.
1. Split the data into a training set, a validation set and the test set, which will consist
of the rest of the data, to avoid overfitting.
The data is then split into a training set, which will consist of the first 37.5% of the
data, a validation set, which will consist of the next 37.5% of the data, and the test set,
which will consist of the rest of the data, to avoid overfitting.
2. Calculate y¯Tr = 1n
∑n
i=1 y
Tr
i , where n is the number of observations in the training
set. The model where yˆi = y¯
Tr for every i in the dataset will be used as the baseline
model.
Here one is fitting the model y = a0 +  to the training data. This is done to create a
baseline model with a low AAE when no dynamic variables are used to predict BGC. Thus
let yˆTr = yˆV a = y¯Tr.
3. Determine the best dynamic parameters for the first input, which is carbohydrates.
This is done by choosing dynamic parameters τˆ1, ζˆ1 such that the predictions yˆ =
y¯Tr + v1(τˆ1, ζˆ1) are as highly correlated with the observed BGC as possible.
Two grid searches are done to determine the dynamic parameter estimates τˆ1 and ζˆ1.
For the first grid search, the bounds were chosen from experience in fitting Wiener networks
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to other subjects’ BGC. See Algorithm 3 for the bounds used for model fitting in this work.
The first grid search finds τ∗1 and ζ∗1 that satisfy three conditions. First, the correlation rTr
between yTr and y¯Tr + v1(τ
∗
1 , ζ
∗
1 )
Tr, where v1(τ
∗
1 , ζ
∗
1 )
Tr is the vector of observations of the
first dynamic variable in the training set, must be greater than 0. Second, the correlation
rV a between y
V a and y¯V a + v1(τ
∗
1 , ζ
∗
1 )
V a, where v1(τ
∗
1 , ζ
∗
1 )
V a is the vector of observations
of the first dynamic variable in the validation set, must also be greater than 0. Finally, rTr
and rV a are maximized such that the absolute difference between rV a and rTr is minimized.
This is desired because one hopes for uniform model performance on the training, validation
and test sets. While model performance on the test set cannot be assessed until the model
fitting is complete, model performance on the training and validation sets can be assessed.
To satisfy the three criteria, the algorithm determines the 25 pairs of dynamic parameter
estimates that maximize rV a. From these, the dynamic parameter estimates that yield the
smallest value of |rTr − rV a| are chosen. Once this first grid search is completed, a second
finer grid search is performed whose center is (τ∗i , ζ
∗
i ), where the goals for rTr and rV a
are the same as the first grid search. We denote the dynamic parameters found from the
second grid search τˆ1 and ζˆ1, the correlation between observed and predicted BGC in the
training set r∗Tr and the same correlation in the validation set r
∗
V a.
4. Set yˆ1 = aˆ0 + aˆ1v1(τˆ1, ζˆ1), where aˆ0 and aˆ1 are the parameter estimates of a0 and a1
found from least squares.
The simple linear regression model y = a0 + a1v1(τˆ1, ζˆ1) +  is fit in order to minimize
AAE. Since v1(τˆ1, ζˆ1) is the only regressor, the correlations r
∗
Tr and r
∗
V a will remain the
same regardless of the value of aˆ0 and aˆ1 found from this fit. Set yˆ
1 = aˆ0 + aˆ1v1(τˆ1, ζˆ1),
where the superscript 1 on yˆ denotes that one input has been fit.
5. Determine the best dynamic parameters for the second input, which is fat. This is
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done by choosing dynamic parameters τˆ2, ζˆ2 and s2 such that the predictions yˆ =
yˆ1 + s2v2(τˆ2, ζˆ2) are as highly correlated with the observed BGC as possible.
The biggest difference between steps 3 and 5 is the introduction of the a constant
s2. This constant s2 is chosen to be one of ±c2, whichever yields the greater correlation
rV a between y
V a and yˆ1,V a + s2v2(τ
∗
2 , ζ
∗
2 )
V a, where c2 is based on the what the perceived
maximum value of the resulting dynamic variable is. For this work, see Algorithm 3 for
the value of ci used for each i. Otherwise a similar process is used to identify dynamic
and static parameters for each of the other inputs. For input 2, a grid search is done first
in order to identify dynamic parameter estimates and the corresponding static parameter,
denoted τ∗2 , ζ∗2 and s2, respectively. Here the parameters must satisfy three criteria. First is
that the correlation rTr between y
1,T r and yˆTr+s2 v2(τ
∗
2 , ζ
∗
2 )
Tr is greater than r∗Tr. Second
it is desired that rV a ≥ r∗V a. Finally the correlation rV a is maximized such that |rTr− rV a|
is minimized, as done in step 3. If such parameters cannot be found in the first grid search,
then take τˆ2, ζˆ2, and s2 such that the correlation rV a is maximized. Otherwise a second
grid search is done, centered at (τ∗2 , ζ∗2 ), and the same criteria are used to determine the
dynamic parameter estimates τˆ2 and ζˆ2 and a first static parameter estimate s2. Let rTr
denote the correlation between observed and predicted BGC in the training set and rV a
denote the correlation between observed and predicted BGC in the validation set from this
second grid search.
6. Determine aˆ0, aˆ1, and aˆ2, the static parameter estimates when the first two dynamic
variables are present in the model.
Once the grid search is complete, the multiple linear regression model y = a0 +
a1v1(τˆ1, ζˆ1) + a2vi(τˆ2, ζˆ2) +  is fit and the correlation between the observed and predicted
BGC in the training set, denoted r∗, and the validation set, denoted r∗∗, are calculated.
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Table 3.1 Bounds and si used for the first grid search.
Input si LB UB Input si LB UB
1 1 10 60 5 .005 60 110
2 5 150 600 6 2 50 100
3 8 1400 1900 7 2 200 500
4 .0025 10 60 8 .0005 70 120
If r∗ < rTr or r∗∗ < rV a, then set aˆ0 and aˆ1 to their previous values, found in step 4,
and set aˆ2 = s2. If the second grid search was not performed and r
∗ < rTr or r∗∗ < rV a,
then the only change to this protocol is to set aˆ2 = 0 instead of s2. Otherwise if r
∗ ≥ rTr
and r∗∗ ≥ rV a, then the static parameter estimates are set to those found from fitting the
multiple linear regression model. Finally set yˆ2 = aˆ0 + aˆ1v1(τˆ1, ζˆ1) + aˆ2vi(τˆ2, ζˆ2).
7. Repeat steps 5-6 for each of the other 6 inputs, where only the bounds of the grid
searches and si differ for each input.
8. Use a backward stepwise regression to possibly remove regressors from the model to
further improve correlation.
Once the static parameters are determined for all inputs, a backward stepwise regression
is performed. For this backward stepwise regression, the statistic used to determine if a
dynamic variable should be removed from the model is rval. For each dynamic variable vi
that is currently in the model, i.e. for each dynamic variable such that aˆi 6= 0, two models
are fit. One is where all model parameter estimates are held fixed, except that aˆi is set to 0.
For the other, the dynamic parameter estimates are held constant, but a linear regression
model with every dynamic variable still in the model other than dynamic variable vi is fit.
Once this is done for each input, the model with the largest rval is chosen. If this value of
46
rval is larger than the value of rval from the previous steps and the value of rfit is larger
than rfit from the previous model, then the model parameters are updated. Otherwise the
backward stepwise regression is complete. This is repeated until the removal of an input
does not result in an increase in rval from the previous model.
3.4 Modeling Blood Glucose Concentrations of Non-Insulin Dependent
Type 2 Diabetics
We now illustrate our methodology and compare it to other models fit to the same
data. In this study, 24 type 2 diabetics who exhibit significant variation in their BGC
participated in a study in order to determine if their BGC can be accurately predicted
from a Wiener network using activity variables, food consumption and time of day. Since
type 2 diabetes affects each subject differently, a model was fitted for each individual in
the study.
In order to obtain frequent measurements of BGC, the Medtronic MiniMed Continuous
Glucose Monitoring CGMS R© System GoldTM (Medtronic Minimed, Northridge, CA) was
used. The SenseWear R© Pro3 Body Monitoring System (BodyMedia, Inc., Pittsburgh, PA)
was used to measure the activity variables used in building this model. From these devices
measurements of activity and BGC were obtained every five minutes. Subjects were also
asked to record the food that they ingested during this time with a PDA, which used
Weightmania R© Pro software (Edward A. Greenwood, Inc., Cambridge, MA). Other than
the necessary downtime to download the data from these devices, data were collected by
these devices twenty-four hours a day for four weeks. While the SenseWear R© Pro3 Body
Monitoring System can measure over 30 activity variables, Rollins et al. [86] only uses
seven of these, and for this work we will only use three. Of the other four variables, three
of them, carbohydrates, fat, and protein, are food variables that represent the amount of
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Table 3.2 A table of inputs used in the modeling work of Rollins et al.
[86] Those in bold will be used in this work, and the number
in parentheses denotes the input number, i.e. v1 corresponds to
carbohydrates.
Variable Type Variables
Activity Transverse accel.-peaks (4) Energy expenditure (7)
Near body temp. Heat flux (5)
Longitudinal accel.-average Galvanic skin response
Transverse accel. - MAD (6)
Food Carbohydrates (1) Fat (2)
Protein (3)
Circadian Time of day (8)
each consumed in grams over every five minutes. The final one, time of day, allows one to
capture the circadian rhythm of each individual’s body, which has been shown to have an
effect on one’s BGC [106]. It assumes values from 0, denoting midnight, to 1439, denoting
11:59 pm. A table of all inputs is given in Table 5.1.
While the AAE is used to ensure that an accurate model is obtained for each subject,
the determination that a low AAE has been achieved must be evaluated on a per subject
basis. This is because the range of BGC varies from person to person. Thus to adjust
for this, the relative AAE (RAAE) is used to scale AAE. To calculate RAAE, first the
estimated standard deviation σˆ of the BGC in the set of interest must be calculated:
σˆY =
√√√√ 1
n− 1
n∑
i=1
(yi − y¯)2, (3.12)
where n is the number of observations in the data set of interest. Now the RAAE can be
calculated as
RAAE =
AAE
σˆ
. (3.13)
The value of RAAE for a One Touch Ultra R© blood glucose meter (LifeScan, Inc., Milpitas,
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CA) using replicated BGC measurements was found to be 0.59. Thus a model whose RAAE
is near 0.6 for each subject is desirable.
The results of the Wiener networks fit to these 24 subjects are given in Table 3.3. Given
the values of rval in the table, we will consider a model to be excellent if the correlation
rTest between observed and predicted BGC is at least 0.5, very good if at least 0.4, good
if at least 0.3, fair if at least 0.2, and poor if less than 0.2. One can see that in training
and validation, the correlation between observed and predicted BGC is above 0.3 for each
subject, while in the test set this correlation is deemed to be good or better for 14 of the 20
subjects and fair or better for 19 of the 20 subjects. While the RAAE is typically greater
than 0.6, it is still low, indicating that these fitted models predict BGC fairly accurately.
For comparison, models for subjects 1-5 were fit manually using the Solver add-in for
Microsoft Excel R©. For these fits, the static parameters were allowed to run to convergence.
Results for these manual fits and the fits from the presented methodology are presented in
Table 3.4. The results found from manually fitting the Wiener networks and this algorithm
are comparable.
3.5 Concluding Remarks
This article presents a methodology that can find accurate parameter estimates for
Wiener networks that predict frequent BGC measurements in a short period of time. This
methodology uses the correlation between observed and predicted BGC in training and
validation sets as well as the AAE in the training set to produce an accurate model while
avoiding overfitting. It uses an intelligent grid search to estimate the dynamic parameters
and fits a linear regression after the estimation of each input’s dynamic parameters in
an attempt to improve the correlation between observed and predicted BGC from the
Wiener network. This work indicates that the Wiener network shows promise in modeling
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Table 3.3 Results from fitting four weeks of data from four subjects. Here
the first 1.5 weeks of the data was used in training, the next 1.5
weeks was used in validation, and the remainder in the test set.
Training Validation Test
Subject rfit RAAE rval RAAE rTest RAAE
1 0.303 0.731 0.532 0.837 0.513 0.816
2 0.317 0.737 0.504 0.660 0.513 0.714
3 0.375 0.703 0.476 0.666 0.468 0.660
4 0.542 0.594 0.524 0.626 0.444 0.702
5 0.651 0.594 0.677 0.569 0.321 0.779
6 0.494 0.670 0.642 0.591 0.551 0.646
7 0.391 0.719 0.426 0.764 0.429 0.684
8 0.471 0.672 0.399 0.788 0.353 0.824
9 0.504 0.649 0.496 0.692 0.402 0.724
10 0.330 0.686 0.347 0.782 0.333 0.721
11 0.490 0.670 0.369 0.824 0.002 0.962
12 0.356 0.732 0.281 0.732 0.327 0.757
13 0.480 0.658 0.549 0.665 0.393 0.764
14 0.443 0.656 0.452 0.663 0.324 0.739
15 0.449 0.965 0.432 0.854 0.509 1.011
16 0.352 0.742 0.393 0.911 0.291 0.742
17 0.444 0.539 0.729 0.569 0.220 1.090
18 0.507 0.621 0.601 0.613 0.245 0.749
19 0.315 0.727 0.432 0.667 0.299 0.822
20 0.492 0.666 0.484 0.765 0.222 0.916
Mean 0.436 0.687 0.487 0.712 0.358 0.791
StDev 0.091 0.085 0.113 0.100 0.131 0.119
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Table 3.4 A comparison of model fits. Auto denotes the algorithm pre-
sented in this paper was used to find the model while Manual
denotes that Wiener networks fit manually via the Solver add-in
for Microsoft Excel R©.
Training Validation Test
Subject Algorithm rfit RAAE rval RAAE rTest RAAE
1 Manual 0.42 0.70 0.40 0.81 0.69 0.58
Auto 0.30 0.73 0.53 0.84 0.51 0.82
2 Manual 0.30 0.75 0.43 0.72 0.59 0.69
Auto 0.32 0.74 0.50 0.66 0.51 0.71
3 Manual 0.33 0.70 0.36 0.76 0.51 0.67
Auto 0.38 0.70 0.48 0.67 0.47 0.66
4 Manual 0.53 0.61 0.49 0.67 0.43 0.74
Auto 0.54 0.59 0.52 0.63 0.44 0.70
5 Manual 0.58 0.62 0.57 0.62 0.42 0.79
Auto 0.65 0.59 0.68 0.57 0.32 0.78
continuous-time BGC in non-insulin dependent people.
For this algorithm to be used in a device that noninvasively predicts BGC for a non-
insulin dependent person, a few adjustments will need to be made. Firstly, the data used
here measured carbohydrates, fat and protein measured to the nearest tenth of a gram for
each meal. Any device that noninvasively measures BGC must have a simple way to enter
food quantities. Manually measuring food quantities is time consuming, and thus those
who wear the device will likely not properly estimate their food intake. This will reduce
the accuracy of the model fitted by the device.
A second issue is the calibration of the device. In this work, BGC was measured
every five minutes. For someone who does not typically use a CGMS, such frequent BGC
measurements will be unavailable. These frequent measurements are also not possible
using a glucose meter over a period of several days due to discomfort from constant finger
51
pricking. Thus a novel scheme must be devised to automatically monitor BGC under
infrequent data collection.
A final challenge to consider is that the parameters are not time and space invariant.
For a type 2 diabetic, the pancreas’ ability to produce insulin changes over time, and
the body’s insulin sensitivity also changes over time. Thus the rate at which the body
converts glucose to energy changes over time. This implies that the model found from this
methodology to predict one’s BGC today may not accurately predict BGC a year from
now. While this methodology allows one to determine a model to accurately predict BGC
quickly, there may be a way to predict changes in the parameters over time.
If these challenges can be overcome, then the development of a device that can nonin-
vasively predict BGC in non-insulin dependent humans could become reality. This device
would eliminate the need for a catheter, which is used by most continuous glucose monitor-
ing systems on the market, and thereby eliminate much of the discomfort experienced by
those who use a CGMS regularly. While this device will be useful for those with non-insulin
dependent type 2 diabetes, anyone who is not insulin dependent and wishes to monitor
their BGC could benefit from such a device.
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Appendix
Pseudocode for the proposed algorithm is given below. For simplicity, the full algorithm
is broken up into four algorithms. Algorithm 1 describes how the dynamic parameter
estimates are obtained. Algorithm 2 describes how the static parameter estimates are
obtained. Finally algorithms 3 and 4 set up the grid searches for the dynamic parameters.
The first grid search uses intelligent choices for determining the grid to search. For
example, it has been shown that most carbohydrates are converted to glucose and then
energy by the body within two hours of ingestion. This amount of time needed for the
carbohydrates to be utilized by the system, i.e. the human body, can be viewed as the
residence time. For a Wiener network, input i has residence time 2τiζi. Thus the grid
search was designed so that the center of the grid search yielded a residence time around
120 minutes. Other food variables are known to take longer to be converted into glucose
and utilized as energy, and the activity variables appear to have a short residence time in
our experience. However, the dynamic parameter τi for input i varies among the activity
variables.
As for the second grid search, the values of τ to be used are determined by the value of
τ ′i found from the first grid search since the candidates for τ from the first grid search are
equally spaced. The values of ζ used for the grid search are also dependent on ζ ′i, but in
some cases the grid generated from it includes negative values of ζi. If this is the case, the
minimum value used in the grid search for ζi is set to 0.0001. Then equally spaced points
between 0.0001 and the maximum value as determined by ζ ′i are used for the second grid
search instead.
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Algorithm 1 Summary of grid searches for dynamic parameters.
Let yTr denote the observed BGC in the training set and yV a the observed BGC in the validation set.
Let yˆTr denote the predicted BGC in the training set and yˆV a the predicted BGC in the validation set.
Let vTi denote dynamic variable i in the training set and v
V
i dynamic variable i in the validation set.
yˆ = [yˆTr yˆV a] = y¯Tr =
1
n
∑n
i=1 yi, where n is the number of observations in the training set.
Set up first grid search. See Algorithm 3.
Let n1 be the length of τ and n2 be the length of ζ.
Let Rf , Rv be n1 × n2 matrices and r∗ = r∗∗ = 0.
while i=1 to 8 do
for j=1 to n1 do
for k=1 to n2 do
rf1 = Corr(y, yˆTr + siv
T
i (τj , ζk)), r
v1 = Corr(y, yˆV a + siv
V
i (τj , ζk))
rf2 = Corr(y, yˆTr − sivTi (τj , ζk)), rv2 = Corr(y, yˆV a − sivVi (τj , ζk))
Choose t such that rft = max{rf1, rf2}.
Set Rfjk = r
ft and Rvjk = r
vt
end for
end for
if maxRf < r∗ then
Choose j, k such that Rvjk = maxR
v.
Set τˆi = τj and ζˆi = ζk.
break
end if
Choose j, k such that |Rfjk −Rvjk| is minimized, Rfjk > r∗ and Rvjk > r∗∗.
r∗ = Rfjk, r
∗∗ = Rvjk
Determine new grid for grid search whose center is (τj , ζk). See Algorithm 4.
Let this grid be n1 × n2 and Rf2, Rv2 be n1 × n2 matrices.
Let S be an n1 × n2 matrix whose entries are 1.
for j=1 to n1 do
for k=1 to n2 do
rf3 = Corr(y, yˆTr + siv
T
i (τj , ζk)), r
v3 = Corr(y, yˆV a + siv
V
i (τj , ζk))
rf4 = Corr(y, yˆTr − sivTi (τj , ζk)), rv4 = Corr(y, yˆV a − sivVi (τj , ζk))
Choose x such that rfx = max{rf3, rf4}.
Set Rf2jk = r
fx and Rv2jk = r
vx
if rfx = rf4 then
Sjk = −1
end if
end for
end for
Choose j, k such that |Rf2jk −Rv2jk | is minimized, Rf2jk ≥ r∗ and Rv2jk ≥ r∗∗.
Set r∗ = Rf2jk and r
∗∗ = Rv2jk .
Set τˆi = τj and ζˆi = ζk.
end while
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Algorithm 2 Summary of algorithm’s determination of static parameters.
Let yˆ be the predicted values of BGC from the grid search.
Fit the model y = β0 +
∑
i kept βivi(τˆi, ζˆi) +  via least squares.
Determine yˆ∗Tr and yˆ
∗
V a from the least squares parameter estimates
rfit = Corr(yTr, yˆ
∗
Tr).
rval = Corr(yV a, yˆ
∗
V a).
if rfit > r
∗ & rval > r∗∗ then
Set yˆ = yˆ∗ from least squares fit, r∗ = rfit and r∗∗ = rval.
else
Set βˆi = ±Sjk
Set yˆ = yˆ found from grid search.
end if
Determine if removing regressors results in fitting the validation dataset better.
Algorithm 3 Setup for first grid search.
τ = [11 12 13 · · · 60]
ζ = [.001 .005 .01 .015 .02 .03 .04 .08 .12 · · · 2]
s = [1 5 8 .005 2 8 .0005]
if i = 2 then
τ = [153 156 159 · · · 300]
else if i = 3 then
τ = [1410 1420 1430 · · · 1900]
ζ = [.01 .01 + 1.49/56 .01 + 2 ∗ 1.49/56 · · · 1.50]
else if i = 5 then
τ = [61 62 63 · · · 110]
ζ = [.01 .01 + .34/56 .01 + 2 ∗ .34/56 · · · .35]
else if i = 6 then
τ = [51 52 53 · · · 100]
else if i = 7 then
τ = [206 212 218 · · · 500]
else if i = 8 then
τ = [71 72 73 · · · 120]
ζ = [.001 .001 + .08/56 .001 + 2 ∗ .08/56 · · · .081]
end if
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Algorithm 4 Setup for second grid search.
Let τ ′i and ζ
′
i denote the parameter estimates chosen from the first grid search.
τ = [τ ′i − .95 τ ′i − .9 · · · τ ′i τ ′i + .05 · · · τ ′i + .95]
if i = 3 then
τ = [τ ′i − 9.5 τ ′i − 9 · · · τ ′i τ ′i + 0.5 · · · τ ′i + 9.5]
else if i = 2 then
τ = [τ ′i − 2.85 τ ′i − 2.7 · · · τ ′i τ ′i + 0.15 · · · τ ′i + 2.85]
else if i = 7 then
τ = [τ ′i − 5.7 τ ′i − 5.4 · · · τ ′i τ ′i + 0.3 · · · τ ′i + 5.7]
end if
if i = 3 then
if ζ′ − 1.48/56 < .0001 then
c =
ζ′i+1.48/56−.0001
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ζ = [.0001 .0001 + c .0001 + 2c · · · .0001 + 54c ζ′i + 1.48/56]
else
ζ =
[
ζ′i − 1.4856 ζ′i − 1.4856 + 2.963080 ζ′i − 1.4856 + 5.923080 · · · ζ′ − 1.4856 + 162.83080 ζ′i + 1.4856
]
end if
else if i = 5 then
ζ =
[
ζ′i − .3356 ζ′i − .3356 + .663080 ζ′i − .3356 + 1.323080 · · · ζ′i − .3356 + 35.643080 ζ′i + .3356
]
else if i = 8 then
if ζ′ − .079/56 < .0001 then
c =
ζ′i+.079/56−.0001
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ζ = [.0001 .0001 + c .0001 + 2c · · · .0001 + 54c ζ′i + .079/56]
else
ζ =
[
ζ′i − .07956 ζ′i − .07956 + .1583080 ζ′i − .07956 + .3163080 · · · ζ′ − .07956 + 8.693080 ζ′i + .07956
]
end if
else
if ζ′i = .001 then
ζ = [.0001 .0002 · · · .0049]
else if ζ′i ≤ .04 then
ζ = [ζ′i + .001 ζ
′
i + .002 · · · ζ′i − .002 ζ′i − .001]
else if ζ′i = 2 then
ζ = [1.965 1.97 1.975 · · · 2.095 2.1]
else
ζ = [ζ′i + .002 ζ
′
i + .004 · · · ζ′i − .004 ζ′i − .002]
end if
end if
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CHAPTER 4. THE DEVELOPMENT OF A MODEL-BASED
NONINVASIVE GLUCOSE MONITORING DEVICE FOR
NON-INSULIN DEPENDENT PEOPLE
A paper to be submitted to Computers and Chemical Engineering
Derrick K. Rollins, Lucas P. Beverlin, Kaylee Kotz, Nisarg Vyas, David Andre, Greg
Welk, and Warren Franke
Abstract
Continuous-time glucose monitoring (CGM) effectively improves glucose control by
providing frequently sampled information that allows the user to associate changes in their
glucose levels with changes in their behavior. Currently, the most widely used and effective
CGM devices rely on a sensor that is inserted invasively under the skin. Due to invasiveness
and cost, the primary users of current CGM devices are insulin dependent people (type
1 and some type 2 diabetics). This research is concerned with the development of a
non-invasive CGM device that would be used by health conscious non-insulin dependent
people (including non-diabetics) that would help reduce obesity as well as the onset and
the progression of type 2 diabetes. Specifically, this work seeks to develop an accurate
device that uses food, activity and stress variables to infer glucose concentration at the
rate of CGM devices, i.e., every 5 minutes. Using 22 test subjects with 4 weeks of data
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collection each, results have been obtained to support the modeling viability necessary
to build a monitoring device. Accomplishments include the ability to develop subject-
specific models under several modeling challenges and restrictions. Results are presented
for models developed after three days, 2 weeks and four 4 weeks that support an initial
calibration period of three days with accuracy improving over time and no need for lancet
measurements after 3 to 4 weeks. Thus, since the model does not drift, this device would
not appear to need glucose measurements for calibration once it is fully calibrated to the
user wearing the device.
Keywords: Soft Sensor, Wiener Modeling, Block-Oriented Modeling, Glucose Modeling
4.1 Introduction
Recent research has supported the belief that real-time, frequent, glucose monitoring
can improve blood glucose control over infrequent monitoring provided through the use
of lancet glucose meters [60, 105]. Frequent glucose measurement capability is referred to
as continuous-glucose monitoring (CGM). Although not really continuous, current devices
can deliver on-line glucose measurements as fast as every five minutes. Nonetheless, this is
a substantial increase over lancet monitoring that only produces a few values per day, at
best. CGM improves the user’s ability to achieve better glucose control by providing highly
frequent, real-time, glucose concentration levels that enables the user to see relationships
between glucose levels and recent activity behavior and/or food consumption. For example,
a user is able to see immediately the impact of the size of a meal on the level of glucose
change along with the duration.
Currently, the most widely used CGM devices, such as the Minimed Guardian R© REAL-
Time System (Medtronic Minimed, Northridge, CA) [9] and the SEVEN R© PLUS System
(DexCom, Inc. San Diego, CA) [3], rely on a sensor that is inserted invasively under
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the skin. Sensors cost from $35 to $60 and last 3 days to a week. Thus, two significant
drawbacks of these devices are comfort and cost. Given these drawbacks, these devices
are not widely used except by insulin dependent users that depend strongly on frequent
monitoring to reduce large swings in glucose variation. For this reason, these devices
are less likely to be used by non-insulin dependent people, including non-diabetics, pre-
diabetics, and non-insulin dependent type 2 diabetics. It is, therefore, the objective of this
research to develop a glucose monitoring device with acceptable attributes for non-insulin
dependent people. Our belief is that by achieving this objective, a significant advancement
can be made in reducing the number of people that are diagnosed with type 2 diabetes
and the number of type 2 diabetics who require insulin for controlling their blood glucose
concentration.
To accomplish our objective, we feel that this CGM device must have the following
attributes:
1. Completely non-invasive
2. Simple or no reliance for food entry
3. Relatively short calibration period
4. Require few to no lancet measurements for calibration
5. An accuracy that is comparable to lancet meters
More specifically, this research proposes to use an inferential sensor for BGC that uses
only noninvasive inputs that updates every five minutes and is calibrated from four lancet
BGC measurements per day after only a few days of data collection. Thus, since a sensor
is calibrated from user data, the model developed for each person is said to be ”subject-
specific.” Our approach to achieve this goal is to use a novel modeling method to infer
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Figure 4.1 The SenseWear R© Pro 3 armband of BodyMedia, Inc
BGC using non-invasive input measurements for each subject from variables representing
food, activity, circadian rhythm, and stress levels. The main component of this system
is a SenseWear Pro 3 armband (BodyMedia, Inc., Pittsburgh, PA) shown in Figure 4.1.
This armband will automatically collect the wearer’s activity and stress data in the form
of several inputs. The food information will be entered manually by the user via the time
stamp button on the armband. The model and model development algorithm will reside in
the armband and will use a Wiener approach based on the work of Rollins et al. [86]. Data
from a lancet glucose meter will be entered automatically or manually and will be used
to develop a subject-specific model for the person wearing the device. After the model is
completely developed, lancet measurements will no longer be needed for calibration. An
interface device will be connected to the armband to display the glucose in five minute
intervals. To our knowledge there is no truly non-invasive device or approach that uses the
combined set of these types of input variables to infer glucose concentration from a model
in real time.
The efficacy of this approach is demonstrated using 22 pre-diabetic and non-insulin
dependent type 2 diabetic subjects. About 4 weeks of IRB approved data collection was
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taken on each subject. For these subjects, modeling results will be given for three model
development periods: three days, one week and two weeks. For these training periods,
zero, one week, and two weeks of validation data, respectively, as well as 25 days, two
weeks, and zero days of test data, respectively, are available for cases with four weeks of
total data collection.
The challenges of the modeling problem include estimating a large set of dynamic
and static parameters from a small set of training samples, minimizing the possibility of
overfitting, a lack of initial steady state data, utilizing meals with a designation of small,
medium and large in the model, as well as frequent and arbitrary removal of the armband.
Through novel modifications of the Rollins et al. [86] approach, this work demonstrates an
ability to overcome these challenges. Thus, this work has promising potential to develop an
effective inferential continuous-time BGC sensor for the target population of non-insulin
dependent people. This article presents this work by providing details of the proposed
approach in the next section. After this section, the next one presents modeling results for
the 22 subjects for the three training periods given above. The last section summarizes
this work and discusses future work that will lead to a proof-of-concept study for the
development of a prototype monitoring device.
4.2 The Modeling Approach
The basic objective of this work is the development of a ”soft sensor,” (also called a
”virtual sensor”) subject-specific, blood glucose concentration (BGC) monitoring system
that can be accurately obtained with a very small amount of data. A soft sensor is basically
an inferential model that is developed from process data or other measured variables that
are termed inputs. This approach has seen wide applications in process monitoring and
control applications in recent years [33, 63] due to advancements in computer hardware,
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software, and measurement technology. While inferential modeling of BGC has been done
by a number of researchers [25, 27, 77, 79, 96, 99], particularly in type 1 applications, this
is the first approach that we are aware of that seeks to develop an inferential model for
non-insulin dependent subjects using infrequent lancet measurements from the subject’s
personal glucose meter. This is the major challenge because the frequency of BGC data for
model building and inference is much less than the virtual measurement rate of 5 minutes.
This limitation can potentially restrict the number of parameter estimates and the use of
previously measured BGC in inference, and thus, severely impact accuracy.
The information for the development of a soft sensor comes from two sources, the re-
sponse data set and the input data set. Since the information content of BGC concentration
is quite limited in this approach, our proposed modeling approach strongly relies on the
input data set for information on glucose behavior. More specifically, the input data set
consists of meal size with three levels, and six variables from the armband. The inputs are
shown in Table 4.2. The ability to map the available input/output information to accurate
sensor measurements depends on the model structure, the model building procedure, and
the inferential algorithm that we are calling the ”Inference Engine.” The model structure
consists of the mathematical functions and the network that tie these functions together.
The model building (i.e., identification) procedure is the process of using input/output
information to estimate the values of unknown parameters in the mathematical functions.
The Inference Engine is the equation used to obtain the soft sensor measurements at the
desired sampling frequency. This equation represents final input selection and parameter
estimation, and the use of lancet glucose measurements to enhance reliability. The purpose
of the next three sections is to describe these three components of the proposed technique
in detail.
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Table 4.1 Input variables: Food (1); Armband (2-7)
Input Name
1 Food
2 Transverse acceleration - peaks
3 Heat flux - average
4 Longitudinal acceleration - average
5 Transverse acceleration - MAD
6 Galvanic skin response - average
7 Time of day
4.3 Modeling Structure
The modeling structure of this application must be capable of accurate parameter
estimation under a small sample size n, effectively handling several inputs with different
dynamic behavior, and mild extrapolation. The modeling network we have chosen is the
Wiener block-oriented network shown in Figure 5.1. As shown, each input i enters a
separate linear dynamic block and the outputs from these blocks are collected into non-
observable variables (vi). These vi are then passed through a static block which can be
any type of function. The Wiener network is defined by the attribute of allowing separate
dynamic behavior for each input and this is a critical reason that it is unique for this
application where the input dynamics can be quite different. This attribute is also exploited
to breakdown the correlation of inputs via the passing of their weakly correlated dynamic
counterparts through the static block.
The dynamic function that we have selected for this application follows the modeling
work of Rollins et al. [86] and it is:
τ2i
d2vi
dt2
(t) + 2τiζi
dvi
dt
(t) + vi(t) = τai
dxi
dt
(t) + xi(t), (4.1)
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Figure 4.2 A graphical representation of the Wiener network. Each of the
p inputs, xi, are passed through a separate linear dynamic block
of Gi and collected and passed through a static function f(V )
to give output η.
x1
x2
ηf(v)
v
v1
v2
vp
G1(s)
G2(s)
Gp(s)xp
...
Using backward difference finite derivative approximations, Equation 5.1 gives [86]
vi(t) =
2τ2i + 2τiζi∆t
τ2i + 2τiζi∆t+ ∆t
2
vi(t−∆t)− τ
2
i
τ2i + 2τiζi∆t+ ∆t
2
vi(t− 2∆t)
+
τai∆t+ ∆t
2
τ2i + 2τiζi∆t+ ∆t
2
xi(t−∆t)− τai∆t
τ2i + 2τiζi∆t+ ∆t
2
xi(t− 2∆t) (4.2)
which can be rewritten as
vi,t = δ1,ivi,t−∆t + δ2,ivi,t−2∆t + ω1,ixi,t−∆t + ω2,ixi,t−2∆t (4.3)
such that ω2,i = 1 − δ1,i − δ2,i − ω1,i. This constraint is used to impose a unity gain
restriction for the linear dynamic blocks. Here the sampling time is ∆t. In the Laplace
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domain, the linear dynamic functions are
Gi(s) =
Vi(s)
Xi(s)
=
τais+ 1
τ2i s
2 + 2τiζis+ 1
(4.4)
Note that the number of dynamic parameters associated with each input is three.
This small number is a strength that we exploit to obtain parameter estimates under
limited sampling as we discuss below. The function f(V ) is called the static function and
is a function of vi,t, i = 1, . . . , p. This function can theoretically be of any form. For
effectiveness under mild extrapolation and parameter estimation (as discussed below) we
have chosen a linear regression model of the form:
yt = ηt + t = a0 + a1v1,t + · · ·+ apvp,t + t (4.5)
where t is the error term and assumed to be independently normally distributed with
mean 0 and variance σ2 for all t.
As stated in Rollins et al. [86], the modeling objective is simply to maximize the true
but unknown correlation coefficient between measured and fitted BGC. This quantity is
represented by and estimated by rfit. Thus, under this criterion a model is considered
useful, if, and only if,
ρy,yˆ > 0. (4.6)
Since the degree of usefulness increases with ρy,yˆ, the goal is to obtain the largest (as
close to the upper limit of 1) value as possible. Due to the highly complex mapping of
the parameters into the response space of rfit, the following indirect criterion is used in
obtaining the parameter estimates as described in Rollins et al. [86]:
Maximize rfit by minimizing SSE
Θ
=
n∑
i=1
(yi − yˆi)2
Subject to: ζi > 0, τi > 0 ∀i, (4.7)
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4.4 Model Identification Procedure
Using the Wiener network with the functional forms of given by Equations 1-5, we have
developed a procedure that can accurately estimate the 3p dynamic parameters and the
p + 1 static parameters even when the number of sampling times (n) is much less than
4p+ 1, the total number of dynamic and static parameters. This procedure requires each
input to have a separate set of dynamic parameters as met by the Wiener network but
not other common networks (e.g. an Auto Regressive Moving Average with eXogenous
(ARMAX) variables) [86]. Here the dynamic parameters for each input separately. This
can be done by exploiting the fact that, with aj = 0 except for j = 0 and j = i, rfit for the
model
yt = a0 + aivi,t + t, (4.8)
depends only on the dynamic parameters associated with input i, i.e., τi, ζi and τai. A proof
of this is given in Appendix A. Therefore, the proposed model identification procedure
estimates the dynamic parameters for each input using Equation 4.8, one input at a time.
Note that at most five parameters are estimated each time which is less than n = 12 for
three days of data collection. After obtaining the dynamic parameters for each input, with
their values fixed, the p = 7 (maximum value) static parameters under Equation 4.5 are
estimated which is also less than n = 12.
To estimate parameters, the model identification procedure uses either one data set
(training only) or two data sets (training and validation) depending on the amount of
available data. When using one data set, the number of inputs may be restricted to the
most reliable set (e.g., meal and the best arm band variable) and the optimization goal
under Equation 4.5 or Equation 4.8 is to maximize rfit under the criterion of Equation
4.7. This estimation procedure is said to be “unsupervised” [47]. When enough data
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are collected to split the data into a training and validation set, “supervised” training is
used for estimating the dynamic parameters and unsupervised training is used to obtain
the static parameters. To dynamically fit similar behavior in both data, the dynamic
parameters are adjusted under Equation 4.8 to give similar yet high rfit values for the
training and validation data sets. This procedure is used to guard against overfitting, i.e.,
fitting BGC behavior in the training set that is not due to true variation in BGC. The
success of supervised training is evaluated through the use of a third set of data called the
“test set” which requires enough data to split the data into three sets.
Effective use of Equation 4.3 depends on accurate initial values for the vi’s. These values
are needed at the start of data collection and anytime the armband is placed on the arm
for use after having been removed. When the dynamics for an input are fast, the accuracy
of the initial values is less of a concern because vi will stabilize relatively quickly. We
have developed ways to obtain initial values for the vi’s under three scenarios: 1. Start of
data collection; 2. Short armband removal periods and; 3. Long armband removal periods.
At the start of data collection we use values that we have obtained and evaluated from
modeling the 22 subjects. For short removal periods, defined to be less than an hour, we
use the vi values at the time the armband was removed. For long removal periods, defined
to be greater than an hour, we will use either a standard start up set of values or their
values at the time the armband was removed depending on the length of time the armband
was off the arm and the dynamics of the input variable. At present, this relationship has
not been finalized and is still a topic of considerable research.
4.5 Development of the Inference Engine
After obtaining a full set of parameter estimates two more refinements are done before
the proposed method is commissioned for real-time monitoring. The first one is elimination
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of inputs that adversely affect accuracy when combined with the other inputs. This is
accomplished using a backwards elimination strategy that keeps the dynamic parameters
fixed and estimates the static parameters under the model given by Equation 4.5. The first
criterion for input elimination is a negative contribution to rfit either in the training set or
validation set. In the final model all the inputs must have a positive contribution to rfit.
In essence, this means that it is desired that all static parameter estimates must be greater
than 0. A second criterion for input i to be removed is that setting its corresponding ai
to zero increases rfit. Once an input is eliminated, the model is refit with the remaining
inputs and the criteria are analyzed again.
The final refinement involves the use of lancet glucose to help to reduce model bias.
Since these measurements are infrequent and are not measured at a constant rate, it is not
possible to build a correction model based on the correlation of residuals. The correction
equation that we use comes from Rollins et al. [86] where only the most recent measurement,
at t = t∗, is used. This equation, which represents the proposed virtual sensor, is given as
yˆt = ηˆt + (yt∗ − ηˆt∗)λ
t−t∗
∆t (4.9)
subject to t > t∗ and 0 < λ < 1, where λ is an adjustable constant, ηˆt is the estimated
BGC at time t under the Equation 4.5 model, ηˆt∗ is the estimated BGC at time t = t
∗
under the Equation 4.5 model, yt is the virtual (i.e., soft) sensor value for the proposed
method at time t, and yt∗ is the lancet BGC measurement at t = t
∗, which is assumed to be
measured without error. Note that yt∗ − ηˆt∗ represents that amount of correction and this
correction diminishes as time increases based on the value of λ, which is close to 1. Thus,
by the time the next lancet measurement is taken, yˆt = ηˆt. This means that at t = t
∗,
yˆt ≈ ηˆt∗ , at t = t∗ + ∆t, yt ≈ yˆt∗ , and at t = t∗ + k∆t, with k  1 and before the next
lancet measurement, yt ≈ ηˆt. That is, at the time of the lancet measurement, the proposed
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virtual monitor would display a value close to ηˆt, the next value would be close to the
lancet measurement, as time proceeds the lancet value would have less corrective influence
as the monitor would rely more on the model to infer BGC. When two sets are used to
estimate model parameters, λ can be set to give the most accurate values in the validation
set. When only a training set is used to estimate the model parameters, a default value
can be used based on results from modeling several subjects.
4.6 Clinical Study Results for 22 Subjects
Using 22 test subjects with 4 weeks of data collection (in most cases and slightly under
4 weeks in other cases except for Subject 1 and 8 which had only about 3 weeks of data due
to loss of data), we have obtained results to support the modeling viability necessary to
build an armband monitoring device. It should be noted that these data sets were collected
for another study (see Beverlin et al. [8]) and modifications had to be made to these data
sets for use in this study. First, food quantities, which were in grams, had to be converted
to food indices to mimic time stamping. The meal sizes were modified to represent 2, 3,
or 4 time stamps, for small (e.g., snacks), medium (e.g., regular meals) and large (e.g., a
meal with more than 100 carbohydrates), respectively. Two timestamps were converted to
indices of 1, 0, 0, for carbohydrates, fats and proteins, respectively. Three timestamps were
converted to indices of 2, 1, 1, for carbohydrates, fats and proteins, respectively. Lastly,
three timestamps were converted to indices of 3, 2, 2, for carbohydrates, fats and proteins,
respectively. After investigating how many of these inputs to use in the modeling, it was
determined that only carbohydrates should be used. Hence input 1 in Table 4.2 corresponds
to carbohydrates. Second, the lancet sampling rate was only four times per day at fixed
times. Continuous-time (CT) blood glucose concentrations (BGC) were taken only at 8
am, noon, 4 pm and 8 pm unless unavailable and then the nearest value was taken with
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no more than 4 values used per day. The monitoring period was taken to be from 8 am to
10 pm daily which means that this was the only period that virtual BGC were reported.
Thus, the period from 10 pm to 8 am was taken to be a non-monitoring period to mimic
unnecessary monitoring during the sleeping period.
We are envisioning a device that will develop the virtual sensor (i.e., Equation 4.9)
using the user’s data in multiple phases. The phases that we give here are for the purpose
of evaluation and are not likely to be the ones used in actual practice as the optimal
phases are still under considerable research and will likely be evolutionary as more and
more data become available, such as an adaptive scheme. The first phase in this evaluation
will consist of a period of about three days (i.e. n = 12) and only food will be used to
determine the model under Equation 4.8 (i.e. ηˆt). Future work will evaluate the addition
of other activity variables in this phase. For the purpose of this evaluation, this model can
be considered to be active from day 4 until about day 14, when the second phase model
will be developed. (However, results will be reported for remaining 25 days as a test set.)
The second phase model will be built under Equation 4.5 from about 14 days of data or
about n = 56 sampling times. All inputs will be considered in this phase. The second
phase model will be operational from day 15 to day 28, and producing test sets with up to
14 days of results for analysis and evaluation. After day 28, the third or final phase model
for this evaluation will be developed from 28 days of data or 112 sampling times. Since
there are at most 28 days of data for any subject, the data will be split into two sets, a 2
week training set and a 2 week validation set.
The results of this study are reported using four statistics. The first one is called the
averaged error (AE) and is simply the average value of the residuals:
AE =
m∑
i=1
yi − yˆi
m
. (4.10)
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where m is the number of lancet measurements in the statistic being estimated. The second
one is called the averaged absolute error and is similar to Equation 4.10 except that the
absolute difference is used for the term in the summation as follows:
AAE =
m∑
i=1
|yi − yˆi|
m
. (4.11)
The next statistic is a scaled AAE and is called the relative AAE (RAAE). This measure
of performance is determined by dividing Equation 4.11 by the standard deviation of the
lancet values used to calculate AAE as follows:
RAAE =
AAE√
1
m−1
∑m
i=1(yi − yˆi)2
=
AAE
σˆy
. (4.12)
RAAE is a relative AAE measure that accounts for large spread in the glucose variation
of subjects. For replicated lancet measurement, the study in Rollins et al. [86] determined
RAAE to be about 0.60 for validation. Thus, we will assume that a value around 0.60 is
comparable to the performance of a glucose lancet meter. The last statistic to measure
performance is rfit. Based on the results in Rollins et al. [86] for a type 2 subject and in
Beverlin et al. [8] for these subjects, we set a goal for rfit to be greater than 0.40 with
a value greater than 0.60 considered excellent. Parameter estimation was done using the
Excel R© Solver add-in.
The first results that we present are for the case consisting of 2 weeks of training and
2 weeks of validation and are given for the model under Equation 4.5 only (i.e. ηˆt). These
results, shown in Table 4.6, are the best ones as they represent the largest training set with
the largest validation set. First, evidence that the convergence criterion for training in all
cases was met can be seen by the values of AE being 0.0 for all subjects. In training and
validation AAE averaged about 17.1 mg/dL and 19.4 mg/dL, respectively. This difference
is partly due to bias in the validation set as evidenced by the AE mean value of -2.4 mg/dL.
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For some subjects AE is quite large and as high as 26.0 mg/dL for Subject 12. The average
RAAE values for training and validation are 0.64 and 0.74, respectively, which are close
to the target value of 0.6. Note that for training, RAAE is ≤ 0.70 for 18 subjects and for
validation, RAAE is ≤ 0.70 for 8 subjects. RAAE ranged from a low of 0.50 to a high
of 1.17 on validation cases which can be attributed greatly to the large variation in AE
indicating greater bias for validation data. The values for rfit on training and validation are
very comparable averaging 0.54 and 0.51, respectively. In addition, the modeling objective
of maintaining similar rfit performance on both sets was met quite well.
Next, the results exclusive of food, i.e., only the armband inputs (variables 2-7 in Table
1) are discussed. These results are given in Table 4.6 for 2 weeks of training and 2 weeks
of validation. In this table two sets of validation results are given. The first set is for the
model under Equation 4.5 where the estimate is designated by ηˆt. The second set represents
the soft sensor results determined under Equation 4.9 and are designated by yˆt. Given that
food is not included, the results are actually not that much worse than those in Table 4.6.
The most critical drop is in rfit that went from 0.54 and 0.51 on training and validation,
respectively in Table 4.6 to 0.46 and 0.43 on training and validation, respectively in Table
4.6. For two subjects (3 and 17) the Table 4.6 results are actually better than the Table 4.6
results that used all the inputs in validation under Equation 4.5. In summary, although the
model with just the armband variables performed well, the improvement obtained with the
addition of food was quite significant and indicates that this variable has a large enough
contribution that it should be included. In addition, the armband provides variables that
are very useful in estimating BGC.
The next study is for 1 week of training, 1 week of validation and 2 weeks of testing.
These results are given in Table 4.4. This is the first table with testing results. The training
and validation results in this table are comparable to the training and validation results in
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Table 4.2 Results under Equation 4.5 for the 22 test subjects with 2 weeks
of training and 2 weeks of validation. AE and AAE values are
in mg/dL.
2 weeks Training 2 weeks Validation
Subject AE AAE RAAE rfit AE AAE RAAE rfit
1 0.00 13.31 0.63 0.55 1.42 19.83 0.63 0.53
2 0.00 11.37 0.54 0.71 10.61 17.11 0.64 0.68
3 0.00 10.46 0.65 0.55 10.91 14.88 0.86 0.52
4 0.00 8.88 0.74 0.39 7.09 10.44 0.85 0.42
5 0.00 17.27 0.66 0.44 0.07 14.10 0.69 0.47
6 0.00 12.23 0.70 0.51 -3.36 14.99 0.91 0.50
7 0.00 19.55 0.69 0.51 7.64 13.99 0.66 0.52
8 0.00 16.66 0.78 0.52 0.36 19.48 0.71 0.53
9 0.00 39.11 0.62 0.53 16.05 35.05 0.62 0.54
10 0.00 13.63 0.64 0.62 -0.52 15.69 0.50 0.63
11 0.00 19.19 0.61 0.65 -2.99 21.20 0.63 0.64
12 0.00 35.39 0.59 0.50 26.01 47.26 0.78 0.36
13 0.00 11.79 0.66 0.38 2.58 11.61 0.75 0.30
14 0.00 9.53 0.69 0.38 -5.50 9.55 0.71 0.35
15 0.00 12.04 0.63 0.58 10.82 19.42 0.72 0.62
16 0.00 15.16 0.74 0.62 -2.52 14.40 0.76 0.62
17 0.00 16.79 0.61 0.58 12.16 26.32 0.78 0.48
18 0.00 16.52 0.65 0.50 14.41 17.29 1.17 0.49
19 0.00 34.20 0.49 0.79 1.51 35.89 0.65 0.63
20 0.00 16.73 0.70 0.43 11.60 16.91 0.84 0.42
21 0.00 13.37 0.57 0.7 -0.84 16.03 0.74 0.47
22 0.00 13.11 0.64 0.57 10.33 14.63 0.86 0.48
Mean 0.00 17.10 0.64 0.54 -2.42 19.37 0.74 0.51
Stdev 0.00 8.34 0.07 0.11 9.58 9.18 0.15 0.10
73
Table 4.3 Armband (inputs 2-8 in Table 1) modeling results for the 22 test
subjects with 2 weeks of training and 2 weeks of validation. AE
and AAE values are in mg/dL. AE is not reported for Training
since it is 0 for all subjects.
Equation 4.5 Model (ηˆt) Equation 4.9 Model (yˆt)
2 weeks Training 2 weeks Validation 2 weeks Validation
Sub. AAE RAAE rfit AE AAE RAAE rfit AE AAE RAAE rfit
1 14.54 0.69 0.41 2.57 21.66 0.69 0.40 2.56 21.65 0.69 0.40
2 13.08 0.62 0.64 13.26 20.09 0.75 0.60 10.36 18.12 0.68 0.67
3 10.70 0.67 0.51 11.37 14.67 0.85 0.53 7.69 11.99 0.69 0.61
4 9.49 0.79 0.32 7.26 10.58 0.87 0.39 7.26 10.58 0.87 0.39
5 17.79 0.68 0.42 0.24 14.36 0.70 0.41 0.24 14.35 0.70 0.41
6 12.40 0.63 0.48 -2.17 15.66 0.77 0.47 -2.12 15.70 0.77 0.47
7 19.55 0.69 0.51 7.64 13.99 0.66 0.52 7.44 12.70 0.60 0.58
8 16.86 0.64 0.42 -0.16 20.71 0.66 0.49 0.02 20.67 0.66 0.50
9 42.34 0.66 0.45 26.89 43.42 0.85 0.41 18.18 40.66 0.79 0.47
10 14.28 0.63 0.55 1.75 17.62 0.66 0.49 1.24 16.95 0.64 0.51
11 19.60 0.64 0.53 0.05 24.42 0.70 0.43 -0.20 24.09 0.69 0.44
12 37.70 0.70 0.38 27.37 48.94 0.88 0.33 15.75 42.51 0.76 0.43
13 11.76 0.66 0.38 2.75 11.75 0.76 0.29 1.73 11.07 0.71 0.38
14 9.28 0.67 0.28 -3.99 9.75 0.75 0.33 -3.78 9.13 0.70 0.35
15 12.50 0.66 0.51 11.43 20.89 0.63 0.58 11.38 20.82 0.63 0.58
16 17.75 0.72 0.43 -3.53 14.96 0.65 0.49 -2.92 14.34 0.62 0.51
17 19.09 0.69 0.43 -9.76 25.84 0.77 0.50 -8.36 25.19 0.74 0.60
18 17.09 0.69 0.47 15.78 19.47 1.21 0.38 15.00 18.75 1.17 0.38
19 41.75 0.59 0.60 14.54 37.58 0.68 0.58 14.54 37.57 0.68 0.58
20 17.05 0.72 0.37 11.45 18.06 0.89 0.34 11.43 18.04 0.89 0.34
21 14.78 0.6311 0.53 -2.56 18.73 0.86 0.19 -2.58 18.75 0.86 0.19
22 13.77 0.67 0.55 10.64 16.38 0.96 0.34 -6.13 14.60 0.86 0.38
Mean 18.33 0.67 0.46 -1.88 20.89 0.78 0.43 -1.00 19.92 0.75 0.46
StDe 9.59 0.04 0.09 11.54 10.15 0.14 0.10 8.95 9.32 0.13 0.11
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Table 4.6 with 2 weeks of training and 2 weeks of validation. For several of the subjects
(e.g., subjects 2, 11, 15-17 and 19) the results under the model given by Equation 4.5 (ηˆt)
are excellent. However, there are a number of subjects where rfit < 0.2 on the test set
(e.g., subjects 4, 13, 14, 21 and 22). In terms of improving AAE, the use of Equation 4.9
(yˆt) show a significant but modest improvement in the rfit results in Tables 4.6 and 4.4.
However, a more critical reason for the use of the soft senor equation given by Equation
4.9 is illustrated in Figure 3 for subject 10 based on the results in Table 4.6. The left
plot shows the fit under Equation 4.5 and the right plot show the fit under Equation 4.9.
As illustrated by the right plot, the use of measured glucose provides a correction within
5 minutes that is close to the most recently measured glucose. Since glucose does not
change too rapidly most often for non-insulin dependent subjects, the sensor will reflect
the variations in BGC behavior quite well in a continuous monitoring fashion.
The final set of results is given for 3 days of training under Equation 4.8 for food only. In
addition, for all these subjects, ζi = 0.2 and τai = 0. This was done to increase the degrees
for freedom to estimate the more critical parameter τi and to simplify the optimization.
The best choice for these values is future research work. As Table 4.6 shows, the results
indicate that the model, while significantly worse than the best results in Table 4.6, are
really quite promising for building the model with only 12 samples.
4.7 Concluding Remarks
This article presented preliminary work on the development of a virtual sensor for blood
glucose concentration (BGC) with the objective of using it to develop a monitoring system
that would be used by non-insulin dependent subjects. This device would require users
to wear an armband that is widely used by this targeted group currently and manually
entering meal sizes through the use of a button on the armband. This device would require
75
T
ab
le
4
.4
M
o
d
el
in
g
re
su
lt
s
fo
r
th
e
22
te
st
su
b
je
ct
s
w
it
h
1
w
ee
k
of
tr
a
in
in
g
an
d
1
w
ee
k
of
va
li
d
at
io
n
.
A
E
an
d
A
A
E
va
lu
es
ar
e
in
m
g
/d
L
.
A
E
is
n
ot
re
p
or
te
d
fo
r
T
ra
in
in
g
si
n
ce
it
is
0
fo
r
al
l
su
b
je
ct
s.
E
q
u
at
io
n
4
.5
M
o
d
el
(ηˆ
t
)
E
q
u
a
ti
o
n
4
.9
M
o
d
el
(yˆ
t
)
1
w
ee
k
T
ra
in
in
g
1
w
ee
k
V
a
li
d
a
ti
o
n
2
w
ee
k
T
es
ti
n
g
2
w
ee
k
T
es
ti
n
g
S
u
b
.
A
A
E
R
A
A
E
rfi
t
A
E
A
A
E
R
A
A
E
r fi
t
A
E
A
A
E
R
A
A
E
r fi
t
A
E
A
A
E
R
A
A
E
r fi
t
1
12
.9
0.
55
0.
70
-1
.6
17
.2
0
.7
9
0
.5
2
1
0
.4
2
8
.6
0
.8
8
0
.2
2
1
0
.4
2
8
.7
0
.8
8
0
.2
2
2
11
.6
0.
59
0.
66
0.
4
11
.8
0
.5
3
0
.6
3
9
.5
1
7
.6
0
.6
5
0
.5
7
7
.0
1
5
.6
0
.5
8
0
.7
0
3
7.
5
0.
51
0.
69
-1
.0
11
.2
0
.6
4
0
.5
3
1
3
.9
1
7
.1
1
.0
3
0
.3
5
1
2
.7
1
6
.0
0
.9
6
0
.4
1
4
8.
0
0.
62
0.
60
-0
.4
8.
2
0
.7
4
0
.5
9
8
.0
1
3
.0
1
.0
9
0
.1
5
7
.9
1
2
.9
1
.0
9
0
.1
5
5
16
.7
0.
65
0.
43
-4
.8
17
.7
0
.6
7
0
.4
8
0
.7
1
6
.1
0
.7
8
0
.3
4
0
.2
1
5
.7
0
.7
5
0
.3
7
6
16
.0
0.
67
0.
44
10
.7
14
.4
1
.0
7
0
.4
1
-4
.9
1
5
.6
0
.8
0
0
.3
7
-3
.5
1
5
.6
0
.8
0
0
.4
1
7
26
.9
0.
79
0.
32
-0
.8
14
.0
0
.6
2
0
.5
3
9
.3
1
6
.0
0
.7
5
0
.4
1
9
.1
1
5
.4
0
.7
3
0
.4
4
8
14
.9
0.
74
0.
35
3.
9
22
.7
0
.6
9
0
.3
6
-0
.8
2
1
.5
0
.7
1
0
.3
7
-0
.8
2
1
.5
0
.7
1
0
.3
8
9
38
.6
0.
63
0.
41
40
.6
58
.4
0
.9
9
0
.3
3
2
8
.2
4
6
.1
0
.9
1
0
.2
9
1
9
.9
4
1
.7
0
.8
2
0
.3
7
10
15
.7
0.
65
0.
55
-6
.0
15
.8
0
.7
7
0
.5
0
-1
.0
1
8
.4
0
.7
0
0
.4
9
-1
.3
1
7
.8
0
.6
7
0
.5
1
11
16
.6
0.
43
0.
65
-8
.0
25
.4
0
.7
6
0
.5
2
-8
.8
2
4
.9
0
.7
2
0
.5
8
-8
.3
2
3
.5
0
.6
8
0
.5
8
12
44
.6
0.
68
0.
52
1.
2
30
.1
0
.7
8
0
.5
0
1
7
.3
4
6
.5
0
.8
2
0
.3
6
1
4
.5
4
3
.9
0
.7
8
0
.4
4
13
11
.7
0.
56
0.
63
2.
4
11
.2
0
.6
0
0
.6
4
0
.7
1
3
.3
1
.0
2
0
.1
2
-1
.0
1
5
.5
1
.1
9
0
.2
7
14
9.
2
0.
67
0.
28
1.
4
12
.4
0
.8
1
0
.2
6
-1
.8
9
.3
0
.7
4
0
.1
7
-1
.8
8
.7
0
.7
0
0
.2
1
15
12
.9
0.
62
0.
50
11
.0
13
.2
0
.8
7
0
.6
2
1
6
.3
2
4
.6
0
.7
3
0
.5
4
1
6
.3
2
4
.6
0
.7
3
0
.5
4
16
13
.5
0.
51
0.
75
-6
.8
15
.1
0
.7
4
0
.5
1
-5
.8
1
7
.0
0
.7
4
0
.5
2
-5
.3
1
6
.8
0
.7
2
0
.5
2
17
17
.5
0.
65
0.
53
17
.9
23
.6
0
.9
8
0
.4
2
-1
.4
2
1
.6
0
.6
3
0
.6
0
-1
.1
2
1
.3
0
.6
3
0
.6
0
18
19
.9
0.
65
0.
39
25
.2
25
.4
1
.6
4
0
.4
7
2
0
.1
2
2
.0
1
.3
7
0
.3
9
1
9
.1
2
1
.1
1
.3
2
0
.3
8
19
37
.2
0.
46
0.
81
16
.2
41
.8
0
.7
6
0
.6
6
4
.3
5
0
.8
0
.9
0
0
.6
4
4
.2
5
0
.9
0
.9
0
0
.6
4
20
12
.1
0.
51
0.
76
1.
7
12
.3
0
.5
3
0
.6
8
0
.8
1
9
.5
0
.9
8
0
.3
9
1
1
.4
1
9
.5
0
.9
8
0
.3
9
21
13
.4
0.
62
0.
63
3.
9
14
.3
0
.5
8
0
.6
0
2
.3
1
8
.3
0
.8
3
0
.1
9
1
.9
1
8
.6
0
.8
4
0
.1
9
22
17
.8
0.
72
0.
46
-6
.0
11
.5
0
.8
2
0
.4
6
-1
.7
1
8
.2
0
.8
7
0
.1
8
-5
.1
1
7
.3
1
.0
0
0
.2
7
M
ea
n
18
.0
0.
61
0.
55
-3
.8
19
.4
0
.7
9
0
.5
1
-1
.2
2
2
.5
0
.8
5
0
.3
8
-1
.1
2
1
.9
0
.8
4
0
.4
1
S
tD
e
10
.0
0.
09
0.
15
12
.0
11
.7
0
.2
4
0
.1
1
1
1
.0
1
1
.1
0
.1
7
0
.1
6
9
.7
1
0
.6
0
.1
9
0
.1
5
76
Table 4.5 Modeling results for the 22 test subjects with 3 days of training
and no validation. AE and AAE values are in mg/dL.
Model from Equation 4.5 Model from Equation 4.9
3 days training 25 days testing 25 days testing
Sub. AAE RAAE rfit AE AAE RAAE rfit AE AAE RAAE rfit
1 17.3 0.71 0.31 3.0 19.4 0.73 0.35 2.6 18.8 0.70 0.35
2 14.9 0.76 0.44 -0.1 16.9 0.67 0.48 -0.6 16.2 0.64 0.60
3 8.0 0.70 0.23 -5.8 14.7 0.81 0.33 -4.6 11.9 0.66 0.53
4 7.0 0.46 0.79 5.5 13.5 1.14 0.27 1.0 13.9 1.17 0.33
5 11.4 0.64 0.52 8.5 18.6 0.77 0.24 6.4 17.6 0.73 0.26
6 9.7 0.66 0.60 -3.2 16.2 0.79 0.21 -3.4 16.1 0.79 0.22
7 29.6 0.74 0.35 16.5 44.8 1.84 0.06 17.2 49.7 2.05 0.07
8 8.2 0.66 0.39 -1.2 22.2 0.73 0.37 -0.7 21.4 0.70 0.42
9 32.1 0.46 0.77 28.4 52.6 0.94 0.20 27.1 52.1 0.94 0.30
10 16.1 0.65 0.30 15.1 21.6 0.91 0.43 14.1 20.4 0.86 0.47
11 21.4 0.83 0.10 13.9 26.8 0.81 0.32 12.2 25.5 0.77 0.34
12 51.4 0.85 0.09 12.5 44.2 0.80 0.21 10.0 42.1 0.76 0.29
13 15.1 0.73 0.32 -7.5 15.4 0.92 0.08 -5.0 15.1 0.90 0.17
14 9.3 0.71 0.51 2.9 14.1 1.03 0.00 1.0 14.1 1.04 0.19
15 18.3 0.67 0.50 13.1 20.9 0.76 0.27 11.9 20.3 0.74 0.28
16 17.5 0.63 0.67 -8.7 19.8 0.86 0.35 -7.3 19.4 0.85 0.34
17 29.2 0.77 0.21 1.9 21.4 0.71 0.41 1.7 20.8 0.69 0.44
18 8.1 0.64 0.08 0.0 14.9 0.64 0.31 -0.1 14.6 0.63 0.38
19 40.5 0.48 0.74 19.1 44.6 0.74 0.59 19.1 44.6 0.74 0.59
20 21.5 0.76 0.27 -4.0 16.9 0.80 0.21 -3.8 16.6 0.79 0.21
21 15.6 0.58 0.66 -0.9 21.3 0.97 0.29 -1.1 21.3 0.97 0.29
22 11.8 0.64 0.59 2.5 15.7 0.81 0.37 2.0 15.2 0.79 0.40
Mean 18.8 0.67 0.43 -4.5 23.5 0.87 0.29 -4.5 23.1 0.86 0.34
StDe 11.5 0.11 0.22 9.9 11.7 0.25 0.14 9.0 12.1 0.30 0.13
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Figure 4.3 Modeling results for subject 10 with two weeks training and 2
weeks of validation showing the model fit under Equation 4.5
(left plot) and Equation 4.9 (right plot).
four lancet measurements per day as current invasive continuous-time monitoring systems
require. However, for this system, once the model is fully developed, which will likely
require 2 to 4 weeks, lancet measurements will be less critical for accuracy and may not be
necessary for some subgroups such as non-diabetic subjects.
Future work will involve running clinical studies under the protocol that subjects will
follow when wearing the device such as time stamping for meal size and using only their
glucose meter to collect data. If these studies show promise and continued improvement
in the modeling technique, we hope to develop a prototype armband and evaluate it on
several subjects.
While we have overcome many challenges such the use of a food index, the lack of initial
conditions, frequent and long term removal of the armband, and multiple input, subject-
specific modeling under infrequent sampling, there are still several challenges to overcome.
These challenges include obtaining starting values for parameters for estimation, gaining a
better understanding on the bounds of each parameter, as well as the development of an
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automatic estimation algorithm that will reside in the armband and apply the estimation
method to develop the virtual sensor from on-line data. These are all areas of future
research that we have begun to work to research and the results are quite promising.
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Appendix
The purpose of this appendix is to provide a mathematical proof that rfit, under the
simple linear regression model given by Equation 4.8, does not depend on the model coef-
ficients a0 and ai but only on the explanatory variable vi,t.
With ηt = a0 + aivi,t, rfit is mathematically given by
rfit = ry,η =
∑n
j=1(yj − y¯)(ηj − η¯)√∑n
j=1(yj − y¯)2 ·
√∑n
j=1(ηj − η¯)2
(4.13)
=
∑n
j=1(yj − y¯)(a0 + aivi,j − a0 − aiv¯i)√∑n
j=1(yj − y¯)2 ·
√∑n
j=1(a0 + aivi,j − a0 − aiv¯i)2
(4.14)
=
ai
∑n
j=1(yj − y¯)(vi,j − v¯i)√
a2i
√∑n
j=1(yj − y¯)2 ·
√∑n
j=1(vi,j − v¯i)2
(4.15)
=
a1
|a1|ry,vi (4.16)
Thus, with ai > 0, rfit = ry,vi and for ai < 0, rfit = −ry,vi . This result means that if the
correlation rfit between blood glucose concentration (BGC) and vi is positive, a1 can be set
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to any positive value and rfit will depend only on the behavior of vi which is independently
controlled by the values of the dynamic parameters associated with vi. Conversely, if the
correlation of BGC and vi is negative, a1 can be set to any negative value and rfit will
be greater than 0 and independently controlled by the values of the dynamic parameters
associated with vi.
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CHAPTER 5. A NEW METHOD FOR PREDICTING FUTURE
BLOOD GLUCOSE CONCENTRATIONS IN NON-INSULIN
DEPENDENT TYPE 2 DIABETICS
A paper to be submitted to Computers and Chemical Engineering
Lucas P. Beverlin, Derrick K. Rollins, Kaylee Kotz, Nisarg Vyas, David Andre, Greg
Welk, and Warren Franke
Abstract
The ability to forecast the onset of hypoglycemia or hyperglycemia is very important for
mananging the blood glucose concentration (BGC) of diabetics. Currently, commercially
available continuous glucose monitoring systems can only predict future BGC to warn the
user of the onset of hypoglycemia or hyperglycemia up to 30 minutes into the future. The
purpose of this work is to present a new methodology for constructing (1−α)100% forecast
intervals for the prediction of BGC up to 1 hour before it would occur. In this work, a
Wiener network is first used to predict BGC using food and activity variables as well as
time of day. This model is then used with a k-steps ahead prediction (KSAP) model
in order to predict BGC up to 1 hour into the future. This fitted KSAP model is used
to construct (1 − α)100% forecast intervals for one’s BGC up to 1 hour into the future.
While in this work we forecast the BGC of non-insulin dependent type 2 diabetics, such
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an approach could be used in conjunction with a model that utilizes insulin infusion to
predict the future BGC of an insulin-dependent diabetic.
5.1 Introduction
Diabetes mellitus is a condition where the body’s ability to control its blood glucose
concentration (BGC) has been impaired or destroyed. Unfortunately it is a growing prob-
lem throughout the world, as Zhang et al. [114] report that the global health expenditure
for diabetes is projected to be at least 375 billion US dollars in 2010 and at least 500 billion
US dollars in 2030.
There are two main types of diabetes mellitus. Both of them affect the body’s pro-
duction of insulin, a hormone produced by the β cells of the pancreas that signals cells to
uptake glucose for energy or fat storage. Type 1 diabetes mellitus is a condition where
the β cells are destroyed by the body. What triggers the body to destroy the β cells is
still being investigated, though it is believed to be an autoimmune response [21]. Type 2
diabetes mellitus is characterized by poor control of the body’s BGC. This can be caused
by cells developing insulin resistance and/or the β cells’ inability to produce a sufficient
amount of insulin to promote glucose uptake. Those with type 2 diabetes are at higher
risk for several other health problems, such as obesity, high blood pressure, nephropathy,
neuropathy and blindness [21]. While the onset of type 1 diabetes generally occurs before
the age of 30 and type 2 diabetes after the age of 30, an increasing number of people,
particularly of Pacific Island or south Asian descent are experiencing the onset of type 2
diabetes in their 20s [114].
It has been shown that tight glucose control significantly reduces the risk of complica-
tions in both type 2 diabetics [105] and in type 1 diabetics [72, 113]. To improve glucose
control, type 2 diabetics have several options. Since many newly diagnosed type 2 diabet-
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ics are overweight, altering dietary and exercise habits are typically the first prescription
[5]. Many type 2 diabetics tend to consume an excess of carbohydrates at a meal, which
can lead to overly high BGC, or hyperglycemia, as well as obesity. Exercise has also been
shown to increase insulin sensitivity [81]. If the body cannot produce enough insulin to
promote glucose uptake or if one’s insulin sensitivity has become too weak, then diet and
exercise alone cannot tightly control BGC. In this case medications and/or insulin may be
used to help control BGC.
To assess their current BGC, diabetics use a glucose meter. However, each measurement
requires a finger prick, and thus monitoring one’s BGC constantly throughout the day
using a glucose meter is unfeasible due to discomfort. Over the last fifteen years, diabetics
have seen the advent and evolution of a continuous glucose monitoring system (CGMS).
Typically these devices return predictions of BGC every five minutes. Once data have been
downloaded from the device, diabetics can view a profile of the changes in their BGC over
the course of several days. A new feature found on some newer CGMS models, such as
the Minimed Guardian R© REAL-Time System (Medtronic Minimed, Northridge, CA) [9],
the SEVEN R© PLUS System (DexCom, Inc. San Diego, CA) [3] and the 5-day FreeStyle
Navigator (Abbott Laboratories, Abbott Park, IL) [109], is the ability to warn the user if he
or she is currently hyperglycemic or hypoglycemic, which is the situation where one’s BGC
is abnormally low. This allows the subject to take immediate action in order to return their
BGC to a healthy level. However, to allow for better control, one needs to predict the onset
of hypoglycemia or hyperglycemia before it occurs in order to take preventative measures.
To our knowledge, two of these devices, the Minimed Guardian R© and the 5-day FreeStyle
Navigator, can predict a hypoglycemic or a hyperglycemic episode up to 30 minutes before
it occurs. According to Bode et al. [9], for the Minimed Guardian R©, this amount of time
can be set by the user to be anywhere from 5 to 30 minutes in 5 minute intervals. However,
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there is roughly a 10 minute lag in this device from collecting the sample to measure BGC
and determining the level of BGC [53]. In order to truly predict BGC at a fixed amount
of time into the future, this lag must be eliminated.
The purpose of this article is to present a new methodology for predicting future BGC.
To this end a model that predicts future BGC from current measurements must be con-
structed. First the Wiener network will be used to predict one’s current BGC, with no
lag, based on food and activity variables as well as time of day. Then this model will be
used with a k-steps ahead prediction (KSAP) model in order to accurately predict BGC
in the future. Finally a (1− α)100% prediction interval for one’s BGC at a given time in
the future will be constructed. Such an interval henceforth will be referred to as a forecast
interval, since we are interested in the prediction of a response variable at some point in
the future, though Chatfield [17] uses the term interval forecast.
The proposed methodology is presented with the following outline. First a detailed
description of the Wiener network for multiple inputs and a single output is given to estab-
lish the problem context. After this section a description of the k-steps ahead prediction
(KSAP) model is given and methods for determining a (1 − α)100% forecast interval for
the response variable in such a model is given. The details of the methodology and an ex-
ample to illustrate our methodology’s ability to forecast BGC is given in the fifth section.
Concluding remarks and some ideas for future work are given in the last section.
5.2 The Wiener Network
The Wiener network has a powerful structure for modeling nonlinear dynamic systems.
A block diagram with p inputs and one output is given in Figure 5.1. Each input xi is first
passed through a dynamic linear block, denoted g(xi) and converted into its corresponding
dynamic variable vi. In Rollins et al. [86], the following second-order-plus-lead with dead
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Figure 5.1 A graphical representation of the Wiener model used in Rollins
et al. [86].
x1
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yˆf(v)
v
v1
v2
vp
g(x1)
g(x2)
g(xp)xp
...
time differential equation is used:
τ2i (t,xi)
d2vi
dt2
(t)+2τi(t,xi)ζi(t,xi)
dvi
dt
(t)+vi(t,xi) = τai(t,xi)
dxi
dt
(t−θi)+xi(t−θi), (5.1)
where τi is a time constant, ζi is a damping coefficient, τai is a lead coefficient, θi denotes
dead time, and t represents time. For simplicity, assume that the dynamic parameters
are time and space invariant, i.e. τi(t,xi) = τi and ζi(t,xi) = ζi. Also vi(t,xi) will be
written as vi(t) henceforth. The vectors τa, τ , and ζ will denote all lead coefficients, time
constants, and damping coefficients, respectively.
In order to calculate vi(t), a recursive definition for vi(t) must be determined. This can
be done by using a backward difference approximation for the derivatives in Equation 5.1:
dvi
dt
(t) ≈ vi(t)− vi(t−∆t)
∆t
(5.2)
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and
d2vi
dt2
(t) ≈ vi(t)− 2vi(t−∆t) + vi(t− 2∆t)
∆t2
(5.3)
It should be noted that since an instantaneous change in xi at time t cannot result in an
instantaneous change in vi at time t under this structure. Thus one must approximate
xi(t− θi) with xi(t− θi −∆t) and dxidt (t− θi) with xi(t− θi −∆t) and xi(t− θi − 2∆t):
dxi
dt
(t− θi) ≈ xi(t− θi −∆t)− xi(t− θi − 2∆t)
∆t
. (5.4)
By substituting Equations 5.2 - 5.4 into Equation 5.1,
vi(t) =
2τ2i + 2τiζi∆t
τ2i + 2τiζi∆t+ ∆t
2
vi(t−∆t)− τ
2
i
τ2i + 2τiζi∆t+ ∆t
2
vi(t− 2∆t)
+
τai∆t+ ∆t
2
τ2i + 2τiζi∆t+ ∆t
2
xi(t−∆t− θi)− τai∆t
τ2i + 2τiζi∆t+ ∆t
2
xi(t− 2∆t− θi)
(5.5)
The resulting vi’s are then passed through a static nonlinear block, denoted f(v) in
Figure 5.1. The function f is typically a nonlinear function with respect to the vi’s. Rollins
et al. [86] uses 11 inputs and the nonlinear function
f(v1(t), . . . , v11(t)) = a0 +
11∑
i=1
aivi(t) +
11∑
j=1
bjv
2
j (t) +
10∑
k=1
11∑
l=k+1
ck,lvk(t)vl(t). (5.6)
In this work, the quadratic and second-order interaction terms will be omitted, and three
of the inputs used in their work will be omitted here, thus leaving the static block to be
represented by a linear regression model. Hence the predictions from the Wiener network
are given by
ηˆ(t) = aˆ0 +
8∑
i=1
aˆivi(t|τˆai, τˆi, ζˆi). (5.7)
Let a denote the vectors corresponding to all linear static parameters. They will be col-
lectively referred to as the static parameters. Thus the final resulting model is
y(t) = η(t) + (t), (5.8)
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where (t) is a normally distributed error term with mean 0 and variance σ2. The error
terms are assumed to be independent of one another.
The ability of the Wiener network to assign unique dynamic behavior to each input is
a major advantage it has over other models that have been used to model BGC. While
autoregressive models have been used to predict BGC [83, 96], these models only depend
on previous values of BGC. These models do not utilize inputs that could greatly impact
BGC, such as the amount of carbohydrates consumed. Other models that do allow for an
exogenous input that have been used to predict BGC include autoregressive models with
exogenous variables (ARX models) [28, 79], autoregressive moving average models with
exogenous inputs (ARMAX models) [25, 27], and nonlinear ARMAX (NARMAX) models
that are linear in their parameters [99]. Since all three of these models share the same
shortcoming, we will illustrate this by considering a typical ARX model with two inputs,
each with lag 2.
ym = α0 +α1ym−1 +α2ym−2 +β11x1,m−1 +β12x1,m−2 +β21x2,m−1 +β22x2,m−2 + m, (5.9)
where m denotes a timepoint corresponding to time t. For simplicity, the error term m
will be suppressed, as it is not important in the following derivation. Thus the model can
be written in the form of a single differential equation:
c1
d2y
dt2
(t) + c2
dy
dt
(t) + y(t) = d1
dx1
dt
(t) + d2x1(t) + d3
dx2
dt
(t) + d4x2(t), (5.10)
where each ci, i = 1, 2 and di, i = 1, 2, 3, 4, are constants. Note that the coefficient in front
of y(t) in Equation 5.10 is set to 1 so that the number of constants is equal to the number
of parameters in the ARX model without the intercept. This can be seen by recalling the
backward difference approximations for the first and second derivatives given in Equations
5.2, 5.3 and 5.4. Here however we will assume that θi = 0. Substituting these as well as
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xi(t−∆t) for xi(t) into Equation 5.10,
c1
y(t)− 2y(t−∆t) + y(t− 2∆t)
∆t2
+ c2
y(t)− y(t−∆t)
∆t
+ y(t) =
d1
x1(t−∆t)− x1(t− 2∆t)
∆t
+ d2x1(t−∆t) + d3x2(t−∆t)− x2(t− 2∆t)
∆t
+ d4x2(t−∆t)
(5.11)
To simplify notation, we will rewrite this to use subscripts to denote timepoints, i.e. y(t) =
ym, y(t−∆t) = ym−1:
c1
ym − 2ym−1 + ym−2
∆t2
+ c2
ym − ym−1
∆t
+ ym =
d1
x1,m−1 − x1,m−2
∆t
+ d2x1,m−1 + d3
x2,m−1 − x2,m−2
∆t
+ d4x2,m−1 (5.12)
Now rearranging terms and solving for ym yields
( c1
∆t2
+
c2
∆t
+ 1
)
ym −
(
2c1
∆t2
+
c2
∆t
)
ym−1 +
c1
∆t2
ym−2 =(
d1
∆t
+ d2
)
x1,m−1 − d1
∆t
x1,m−2 +
(
d3
∆t
+ d4
)
x2,m−1 − d3
∆t
x2,m−2 (5.13)
(c1 + c2∆t+ ∆t
2)ym − (2c1 + c2∆t)ym−1 + c1ym−2 = (d1∆t+ d2∆t2)x1,m−1
− d1∆tx1,m−2 + (d3∆t+ d4∆t2)x2,m−1 − d3∆tx2,m−2 (5.14)
ym =
2c1 + c2∆t
c1 + c2∆t+ ∆t2
ym−1 − c1
c1 + c2∆t+ ∆t2
ym−2 +
d1∆t+ d2∆t
2
c1 + c2∆t+ ∆t2
x1,m−1
− d1∆t
c1 + c2∆t+ ∆t2
x1,m−2 +
d3∆t+ d4∆t
2
c1 + c2∆t+ ∆t2
x2,m−1 − d3∆t
c1 + c2∆t+ ∆t2
x2,m−2 (5.15)
One can see that the denominator of each coefficient of an input is c1 + c2∆t+ ∆t
2. Thus
the only parameter that determines the relationship between xi and y are the di’s. This is
very constrictive, in that if we set c1 = τ
2 and c2 = 2τζ, this forces the residence time of
each input to be 2τζ. Thus to use an ARX, ARMAX, or NARMAX model for predicting
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BGC, one must assume that each input to be used in the model has the same residence
time. Given there is some evidence that this is untrue [70], we would prefer to use a model
that does not have this limitation. This model flexibility as well as low parameterization
were the main reasons the Wiener network is used in this work.
5.3 The KSAP Model
In order to predict future BGC, a k-steps ahead prediction (KSAP) model will be used,
as given in Rollins et al. [86]. A step in this situation corresponds to a change in time of
∆t minutes. In this work ∆t = 5 since the measurements of each input and output are
reported every five minutes. Thus, for example, a 6 steps ahead prediction model predicts
BGC thirty minutes after the current measurements have been taken.
In order to motivate the KSAP model, a prewhitening model is defined as (Rollins, et
al. [85])
yt = ηt +Nt, (5.16)
where
Nt =
θq(B)
φp(B)
at,
θq(B) = 1− θ1B1 − θ2B2 − · · · − θqBq, (5.17)
φp(B) = 1− φ1B1 − φ2B2 − · · · − φpBp,
B is a backward shift operator, i.e. Brxt = xt−r for r = 1, 2, . . ., and at is an error term at
time t whose mean is 0 and variance is σ2a where ai is independent of aj for i 6= j. Note
that Nt is an ARMA(p, q) noise term. Let
φp(B)
θq(B)
= Π(B) = 1− pi1B − pi2B2 − · · · (5.18)
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Multiplying both sides of Equation 5.16 by Π(B) yields
Π(B)yt = Π(B)ηt + at. (5.19)
(1− pi1B − pi2B2 − · · · )yt = (1− pi1B − pi2B2 − · · · )ηt + at (5.20)
yt = ηt + (pi1B + pi2B
2 + · · · )(yt − ηt) + at (5.21)
yt = ηt + (Π(B)− 1)et + at, (5.22)
where Πˆ(B) = φˆ(B)
θˆ(B)
and et = yt−ηt. Thus from Equation 5.22 a one step ahead prediction
(OSAP) estimate for yt is given by
yˆt = ηˆt + (Πˆ
∗(B)− 1)eˆt = ηˆt +
(
φˆ(B)
θˆ(B)
− 1
)
eˆt, (5.23)
where Πˆ(B) = pˆi1B + pˆi2B
2 + · · · and eˆt = yt − ηˆt.
The KSAP model will have a similar structure to the OSAP model. Instead of predicting
one timestep ahead, i.e. at t, the KSAP model predicts BGC at timestep t + k − 1. Note
that a KSAP model predicts yt+k−1 rather than yt+k since yt+k−1 is k steps ahead of the
most recent BGC measurement available, which is at timestep t− 1. With the most recent
output yt−1 the KSAP model proposed here gives the following prediction for yt+k−1
yˆt+k−1 = ηˆt+k−1 + (Πˆ∗(B)− 1)eˆt (5.24)
with model
yt+k−1 = ηt+k−1 +N∗t + βt+k−1 (5.25)
where N∗t = Π∗(B)at, Π∗(B) =
φ∗(B)
θ∗(B) = 1 − pi∗1B − pi∗2B2 − · · · , pi∗i are parameters to be
estimated, Πˆ∗(B) = 1− pˆi∗1B− pˆi∗2B2−· · · , pˆi∗i are estimates of pi∗i , and βt+k−1 is an estimate
of the bias at timestep t + k − 1. This bias term is included because the residuals from a
KSAP model will not be white noise. This is due to the serial correlation that is present
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in Πˆ∗(B)− 1 that would not be present in Πˆ(B)− 1 from the OSAP model. To eliminate
this bias, an intercept term φ0 is added to this model and estimated, i.e.
yt+k−1 = ηt+k−1 +N∗t + φ0. (5.26)
There are advantages to using a KSAP model, which shall be referred to as model 2, as
opposed to a Wiener network that does not use outputs, which shall be called model 1, or
a model that only uses outputs, such as an autoregressive model, which shall be denoted
model 3. The first advantage is that model 2 incorporates both inputs and outputs in order
to improve prediction. Model 1 only uses inputs to predict BGC, while model 3 only uses
outputs. Secondly, the outputs used in Model 1 can assist in correcting for a lack of fit
that is inherent to modeling BGC in non-insulin dependent diabetics. Third, the predictive
ability of model 2 far outperforms that of the autoregressive model, which can be seen in
Figure 5.2. As k increases, the predictive ability of model 2 decreases, but its performance
will not be worse than that of model 1, while the predictive ability of model 3 degrades
quickly as k increases.
5.4 The Proposed Methodology
In this section the proposed methodology for constructing (1− α)100% forecast inter-
vals for BGC will be presented. To illustrate this methodology, data collected from two
subjects, denoted subjects 1 and 2 in this work, in a study in Beverlin et al. [8] were used.
In that work, the Medtronic MiniMed Continuous Glucose Monitoring CGMS R© System
Gold
TM
(Medtronic Minimed, Northridge, CA) was used to measure BGC every 5 minutes.
The SenseWear R© Pro3 Body Monitoring System (BodyMedia, Inc., Pittsburgh, PA) was
used to measure the activity variables that were used by the Wiener model every five min-
utes, and subjects recorded their food data using Weightmania R© Pro software (Edward
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Figure 5.2 The observed relationship between k, the use of inputs and/or
outputs in the model and rfit. Taken from [86].
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825 the approach also has potential in noninvasive glucose monitoring
826 using personal meter data for model adaption and calibration.
827 Next, the individual dynamic characteristics of each input are
828 examined to gather insight of their effect on dynamic glucose
829 behavior. This can be accomplished by examining the values of
830 the dynamic parameters and from plotting the vi’s over time. For
831 this discussion the 2006 20/5 FM results are used. For this case
832 the dynamic parameters are given in Table 4 and selected plots
833 of the v’s are given in Figs. 9a, 9b and 9c. These plots also contain
834 glucose response and thus, represent individual dynamic behavior
835 laid over its corresponding glucose behavior. As such, these plots
836 provide insight on the dynamic contributions of the different in-
837 puts to the overall dynamics of glucose response.
838 First, the dynamic effects of the nutrient components are ana-
839 lyzed. Fig. 9a contains plots of vi over time for the carbohydrates
840 and fats variables (protein is not shown for space considerations)
841 and over laid by the measured glucose values. Note that these plots
842 have two vertical axes, one on the left for BG and one on the right
843 for vi. As shown in Fig. 9a, the periodic behavior of these variables
844 is quite different and covers a very wide range. Carbohydrates
845 (CHO) have the smallest effective residence time among the food
846 variables as seen from the last column of Table 4. The overall effec-
847 tive residence times of fats and proteins are more than 4 and 11
848 times, respectively, greater than that for carbohydrates. These val-
849 ues provide a measure of the relative rates at which these three
850 nutrients impact the blood glucose for this subject. From these
851 plots it can be seen that the effects of carbohydrates are much fas-
852 ter and relatively short term. In addition, the effects of fats from
853 different meals generally seem to overlap and their v’s reach min-
854 imum levels once in a 24-h period.
855 Fig. 9b gives the time series plot for v4 (from Transverse accel. –
856 peaks) and v5 (heat ﬂux). As shown in Fig. 9b, v4 matches high fre-
857 quency behavior of glucose quite well. It is found that v8 (from
858 Transverse accel. – MAD) matched the highest frequency behavior
859 the best, but the plot has not been included for space consider-
860 ations). Nevertheless v4, even with a slightly lower frequency
861 behavior than v8, still matches the boxed region (representing
862 the low glucose values changing quickly with high amplitudes)
863 around 9/27 very well. The validity of this very low level, highly
864 oscillatory behavior of glucose seemed questionable at ﬁrst but gi-
865 ven the excellent match with v4, and with the food components
866 exhibiting different dynamic behaviors, it appears to be valid.
867 In addition, one can also examine the plots for v5 (from heat
868 ﬂux) which appears to match the low level of these data well
869 and other patterns in the data on a period of roughly a half of a
870 day; but its periodicity does vary, especially for the validation data.
871 The very low levels appear between 4:00–5:00 am, which were
872 during sleep. Given that the heat ﬂux is the amount of heat loss
873 through the skin, it is expected that this loss would be the least
874 during times corresponding to the longest periods of low activity.
875 However, during sleep, other factors, such as changes in covering,
876 room temperature, dreaming, etc., can also affect heat ﬂux. Thus,
877 it appears that the combination of v4, in terms of periodicity (fre-
878 quency and amplitude), and v5 in terms of low level, validates
879 the behavior of the boxed region and, therefore, appears to be quite
880 useful in explaining this behavior.
881 The ﬁnal analysis concerns the only variable that was included
882 from observing patterns in the data – the time of day (TOD). This
883 variable is the 24 h clock. Its dynamic output, v11, is plotted in
884 Fig. 9c. In a 24 h cycle, the pattern of v11 was very periodic with
885 the minimum occurring around 4:30 am each day. The circadian
886 rhythms of glucose and insulin in humans are well reported in lit-
887 erature [31,32] and the ﬁndings from this analysis also indicate
888 that there appears to be an ‘‘internal clock” for this subject contrib-
889 uting to glucose behavior, especially during periods of low effects
890 from food such as during sleep. To establish this more conclusively
891and widely, more subjects will need to be evaluated under this ap-
892proach given its ability to obtain v11. (Also for space considerations,
893v6, v7, and v9 are not discussed or shown graphically.)
894Next, one might consider the value of this approach for KSA pre-
895diction which is predictive ability k sampling periods (i.e., k times
896Dt) ahead from the most recent glucose measurement. Note that
897since the proposed method does not depend on glucose measure-
898ments but only on inputs (i.e. the models are output error models),
899it does not suffer from the limitations of KSA prediction; namely,
900the need for output measurements and their ability to impact fu-
901ture prediction. For this discussion, an additional model is intro-
902duced that depends only on glucose measurements that will be
903called Model 3 and is described as:
y^tþk ¼ u^0yt þ u^1yt1 þ u^2yt2 þ u^3yt3 þ    ð26Þ 905
906Model 3 exploits serial correlation of current and past outputs to
907ﬁnd optimal values for the u^0s: Model 2 is determined using the
9082006 20/5 FM and Model 3 using measured data for k = 1, 6 and
90912. Model 2 had two additional parameters (i.e., h^1 and h^2) and
910Model 3 had four parameters (i.e., u^0 to u^3). Since for both models
911the parameterization was low compared to the amount of data, the
912impact of these models can be effectively examined through the
913behavior of rﬁt for the training data. These results are given in
914Fig. 10 where rﬁt is plotted against k for both models.
915As shown, rﬁt increases as k increases for both models. Model 2
916approaches Model 1 performance and Model 3 drops rapidly.
917Essentially, this indicates that while the outputs can aid in predic-
918tion when the number of steps ahead is small, it will not aid much
919when the number of steps is greater than 12 (60 min in the future).
920However, the results of Model 2 indicate that predictive accuracy is
921not limited by the size of k but by the accuracy of the input model,
922g^tþkDt . Therefore, not only can the proposed method play a key role
923in feedforward control but also provide critical modeling ability for
924model predictive control since insulin infusion can affect glucose
925performance much longer than one hour or for k > 12.
9265. Concluding remarks
927This article presents preliminary evidence demonstrating that it
928is possible to accurately model blood glucose concentration for
929individuals under free-living conditions for an extended period of
930time using an extensive set of food, activity and stress inputs. In
931actuality, these variables can be considered as disturbances in that
932they act to change glucose levels away from normal levels. By
933modeling the effects of these disturbances this work represents a
934critical advancement toward the goal to tighten glucose levels for
935insulin-dependent as well as non-insulin dependent diabetics. This
936accomplishment can aid considerably in understanding how food,
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Fig. 10. rﬁt versus k for the 2006 20/5 FM under Models 2 and 3.
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A. Greenwood, Inc., Ca bridge, MA) on a PDA. Th inputs u ed by the Wiener network
is given in Table 5.1. The Wiener networks were fit in the same manner as presented in
that paper. The KSAP models were fit to the final two weeks of the data for each subject.
Pr dictions at k = 1, 6 and 12 steps ahead will be analyzed.
First, since N∗t is an infinite sequence, it should be truncated in order to limit the
number of parameters to be estimated. To do this, models ere fitted with 1, 2, 3, . . . ,
terms, i.e.
yt+k−1 = η +k−1 + φ0 + φ1et−1 + at, (5.27)
yt+k−1 = ηt+k−1 + φ0 + φ1et−1 + φ2et−2 + at, (5.28)
and so on. Terms were added until a model was fit where at least one φi failed to be
significantly different from zero. The parameter φi was deemed significant if, for the hy-
pothesis test H0 : φi = 0 versus Ha : φi 6= 0, the value of φˆiσˆφˆi , which is assumed to be a
random sample from a standard normal dis ribution, is larger than 1.96, which corresponds
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Table 5.1 A table of inputs used in the modeling work of Rollins et al.
[86] Those in bold will be used in this work, and the number
in parentheses denotes the input number, i.e. v1 corresponds to
carbohydrates.
Variable Type Variables
Activity Transverse accel.-peaks (4) Energy expenditure (7) Heat flux (5)
Transverse acceleration - MAD (6)
Food Carbohydrates (1) Fat (2) Protein (3)
Circadian Time of day (8)
to p < .05 for this test. The last model where all φi’s were deemed significant was taken
as the model of choice. The number of error terms used for each subject and each k are
given in Table 5.2. For every model, either two or three error terms were used for KSAP
modeling.
When fitting the resulting KSAP model for each k to subject i, the residuals do appear
to be skewed from a normal distribution with mean 0 and some variance σ2i,k, and the
skewness appears to increase as k increases. Histograms of the residual plots are given in
Figure 5.3. To construct an approximate (1−α)100% forecast interval, we will use a similar
calculation as a calculation of a (1 − α)100% prediction interval in nonlinear regression,
but the critical value that is typically used will be increased to account for the skewness.
To further simplify the calculation of this forecast interval, the large sample size allowed
the dynamic parameters to be accurately estimated. Due to the low variance estimates
of the dynamic parameters, it was assumed in the calculation of the forecast interval that
the dyanamic parameters were constants. This allows the dynamic variables found in the
Wiener network to be used as regressors, as the inputs were also assumed to be measured
without error. Thus an errors-in-variable approach, as given in Fuller [35] or Seber and
Wild [90], or factoring in the variance of the dynamic parameters to the forecast interval,
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is not necessary.
From this, an approximate (1−α)100% forecast interval, conditional on vt+k−1, et−1, . . . ,
et−s for a single future observation Yi,t+k−1 from a KSAP model can be constructed as
yˆi,t+k−1 ± tα/2,n−pσˆi,k
√
1 + ci,k, (5.29)
where p is the number of static parameters in the model, tα/2,n−p is the (1 − α/2)100th
percentile of a tn−p distribution, ci,k = w′i,t+k−1(V
′V )−1wi,t+k−1,
w′i,t+k−1 = [1 v1,t+k−1 v2,t+k−1 · · · vp,t+k−1 et−1 · · · et−q], (5.30)
V = [1n v1 · · · vp e1 · · · eq], (5.31)
q is the number of terms in the KSAP model (either 2 or 3), 1n is a vector of length n
whose entries are 1, n is the number of observations used to fit the model, ei is the vector
of residuals of lag i, and σˆi,k is the point estimate of the variance of Yi,t+k−1. Since we are
interested in obtaining a simultaneous confidence band for all values in the range of the
dynamic variables and residuals, we chose to use a confidence band approach, as presented
in Bates and Watts [6]. Thus, for the remainder of this work, an approximate (1−α)100%
forecast interval for Yi,t+k−1 is
yˆi,t+k−1 ±
√
pFp,n−p,ασˆi,k
√
1 + ci,k, (5.32)
where Fp,n−p,α is the (1− α)100th percentile of an Fp,n−p distribution.
In having a large sample size, ci,k is also so small as to be negligable. This is seen in
Table 5.2, in that the coverage of the 95% forecast intervals without ci,k, denoted Coverage
1, are almost identical to those with ci,k, given under Coverage 2. This can also be seen in
that we obtain highly accurate estimates of the static parameters due to the large sample
size. Thus the estimated variance of the static parameters σˆ2(V ′V )−1 is negligable. Hence
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to simplify calculations, one may remove ci,k from Equation 5.32, which yields the following
formula for a (1− α)100% forecast interval:
yˆi,t+k−1 ±
√
pFp,n−p,ασˆi,k. (5.33)
It should be noted that a similar approach was taken to calculate (1 − α)100% confi-
dence intervals for individual Yi,t+k−1 in Gilchrist [39]. Chatfield [16] notes that Gilchrist’s
method may not achieve the desired covered for small n and large k. For this work, n
is very large, typically over 3000, and k is no larger than 12. Thus achieving the desired
coverage seems plausible.
Plots of the models where predictions are made before and after a meal are given in
Figure 5.4. Not surprisingly, the forecast intervals become wider as k increases. While the
coverage is not perfect, one can see that the observed BGC that fall outside of the 95%
forecast interval are only slightly higher than the upper bound of the forecast interval. It
would be far more worrisome if some observed BGC fell well below the lower bound of the
95% forecast interval, as the health implications of hypoglycemia are diabetic shock, coma,
and even death. This does not appear to happen throughout the two weeks of predictions,
regardless of k.
5.5 Concluding Remarks
This article presents a methodology for constructing (1−α)100% forecast intervals for
BGC up to 1 hour into the future. This methodology first utilizes a Wiener network to
predict BGC. This fitted model is then used in a KSAP model in order to improve the
accuracy of predictions. Finally a (1 − α)100% forecast interval is determined from the
KSAP model in order to predict future BGC.
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Figure 5.3 Histograms of the residuals for 1, 6, and 12 steps ahead for two
subjects.
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One weakness of this approach is that if one is predicting BGC too far into the future,
there is no way for this model to take into account food consumption or exercise that occurs
between the current time and the time for the prediction. In this work, since all the food
and activity data were collected prior to fitting the model, it was known when meals and
exercise would take place, and thus our model could account for these future events. If
future meals and exercise are unknown, then the performance of these models, particularly
as k increases, will suffer.
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Table 5.2 Results from the calculation of forecast intervals. Terms is the
number of error terms used in the KSAP model for predicting
BGC k steps ahead for subject i, Coverage denotes the propor-
tion of observations yt+k−1 contained in the 95% forecast inter-
vals calculated from Equation 5.32.
Subject 1 Subject 2
k Terms Coverage k Terms Coverage
1 2 .976 1 3 .979
6 3 .988 6 3 .982
12 2 .985 12 3 .988
While this work was performed on data taken from non insulin-dependent type 2 dia-
betics, such a method could be used, in conjunction with a model that incorporates insulin
infusion, for predicting BGC in diabetics who are insulin dependent. For these people, this
KSAP model that utilizes insulin infusion could warn them ahead of time if their BGC
will become too low or too high. From this, they could take countermeasures to prevent
hypoglycemia or hyperglycemia from even occurring. This would be very useful for type 1
diabetics who are concerned with abnormal BGC during the overnight hours, as an alarm
could sound to wake them in order to allow them to take corrective action.
Unfortunately, for this data, assessing the ability of this approach to detect hypo-
glycemia is difficult. If the signal from the sensor to the CGMS is weak, this can result
in the CGMS reporting lower BGC than what the actual BGC is. This can result in the
CGMS incorrectly reporting hypoglycemia due to weak signal strength. This also causes
error in the model because of the error in the observed BGC from the CGMS. While data
cleaning was performed to remove erroneous BGC measurements from the CGMS, there
were few observations of hypoglycemia in the data used by Beverlin et al. [8]. A further
complaint raised in the literature [20, 37, 57] is that while the accuracy of a CGMS has
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Figure 5.4 Plot of observed and predicted BGC as well as 95% forecast
intervals for each of the models before and after a meal.
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increased over the past 10 years, they are still not as accurate as lancet glucose meters,
which can only give infreqent BGC measurements.
The ultimate goal of this research is to develop a method of forecasting future BGC
for use in a device that measures BGC noninvasively that can warn the user up to an
hour ahead of time of a possible hypoglycemic or a hyperglycemic episode. Such a device,
particularly if false alarms can be minimized, would improve the quality of life for diabetics
everywhere by allowing the user to take corrective action to reduce the occurrence of
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abnormal levels of BGC. While the results in this work are promising, the forecast intervals
for large k must become narrower in order to be used effectively in such a device.
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CHAPTER 6. CONCLUDING REMARKS AND FUTURE WORK
6.1 Concluding Remarks
Many people have attempted to model one’s blood glucose concentration (BGC) over
the last 50 years. While several of these models have had success, there are strengths and
weaknesses associated with each model. The model used in this work, the Wiener network,
has many strengths that other models do not have. The first is that the dynamic parameters
for each input of the Wiener network have phenomenological meaning. The second is that
the Wiener network assigns unique dynamics to each input. This is important in modeling
BGC, as food nutrients, activity, and time of day all affect BGC differently. Many other
models that have been used do not utilize inputs, and of those that have, none to our
knowledge use all the inputs that the Wiener network in this work uses.
One of the weaknesses of the Wiener network is that it is a nonlinear model. Thus
iterative methods will be needed in order to fit the Wiener network. In this work an
algorithm was developed that could determine accurate parameter estimates in order to
create an accurate model in a short period of time. This algorithm can also determine which
inputs should be included in the Wiener network to maximize the correlation between the
predicted BGC from the Wiener network and the observed BGC. Thus this algorithm
was used to produce models that could accurately predict a non-insulin dependent type 2
diabetic’s BGC.
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Although the Wiener network was used to accurately predict BGC in non-insulin de-
pendent type 2 diabetics, there are other hurdles that must be overcome in order to use
such a model in a device that can noninvasively measure one’s BGC. One hurdle is that
there may be model bias. To reduce this bias and increase its accuracy, the model is cali-
brated four times a day using a measurement of BGC from a lancet glucose meter. Another
is the inclusion of food in the model. A timestamping procedure was devised in order to
approximate food intake rather than measure it to the nearest gram as was done for the
models fitted using the algorithm described in Chapter 3. The final hurdle is that most
users will not frequently measure their BGC. Due to a lack of data, some parameters were
set to fixed values to reduce parameterization in order to determine an accurate model
with a very limited amount of data. With these hurdles overcome, the Wiener network
was able to accurately monitor BGC throughout the day with only four weeks of infreqent
data collection.
Another function that could be utilized in such a noninvasive device is the ability to
predict a user’s BGC in the future. If the user has a desired range for their BGC, he or she
could set an alarm to sound if predictions of future BGC indicate that their BGC may leave
the specified range. The Wiener network is used with a k-steps ahead prediction model
to improve prediction of future BGC. This allows us to use both inputs and outputs in
order to improve prediction. By utilizing this model, this work developed an approximate
(1− α)100% forecast interval for BGC up to 1 hour into the future.
6.2 Future Work
While the results of this work will bring us closer to the goal of developing a device
that can noninvasively measure BGC accurately, there is still much work to be done. The
first focus is to improve the accuracy of our model. While the models fit in this work yield
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predictions of BGC that exhibit high correlation with observed BGC, there may be some
measurable inputs that are not being utilized in these models. Identifying such inputs
will increase the ability of these models to track changes in BGC and reduce the average
absolute error. It is also possible that a better model structure that uses current inputs
may be identified.
In this work, the Wiener network has been used to accurately monitor one’s BGC under
infrequent measurements of BGC. However, there are several possible improvements that
could be made. Firstly, these models were fit manually. To be used in the nonivasive
device for measuring BGC, an algorithm must be devised to determine accurate parameter
estimates with a small amount of data. Thus certain parameters may need to be fixed
in order for the algorithm to find a model that accurately predicts BGC. Determining
starting parameter estimates that allow the algorithm to quickly find parameter estimates
that yield an accurate model is another topic of future research.
Another focus on future research is to improve the forecasting capability of the KSAP
model. This capability could allow it to be used to warn the user of the onset of hypo-
glycemia or hyperglycemia in the near future. While the KSAP model produced narrow
forecast intervals when k was small, the width of the forecast interval increased rapidly
as k increased. Thus, currently predicting the onset of hypoglycemia or hyperglycemia an
hour or more ahead of time is difficult, as the width of the forecast interval for large k is
too wide to make a sound judgment on determining whether or not one will have abnormal
BGC at that future time. Modifications to the KSAP model may be necessary in order to
improve performance.
An advantage that this work had that may not be available under free-living conditions
is the knowledge of when future meals will be consumed or future exercise will take place.
In this work, since all data was collected before constructing the forecast intervals, it was
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known if the user would consume a meal or exercise within the next hour, and thus it was
taken into account in predicting future BGC. This information may not be available to
the model used in this noninvasive device under free-living conditions. Thus functionality
must be added to the device that allows the user to warn the device of future food con-
sumption or exercise, as simply increasing the width of the forecast interval to account
for this uncertainty would decrease the ability of the device to accurately predict future
hypoglycemia or hyperglycemia.
This work represents progress toward the ultimate goal of the development of a device
that noninvasively predicts BGC in non-insulin dependent people. Such a device would be
useful to anyone who desires to learn more about how their BGC is impacted by their diet
and exercise regimen as well as time of day. This device would improve the well-being of
anyone who wears such a device.
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